| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | H2AZ2 CHD4 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 6.73e-19 | 67 | 222 | 17 | GO:0031492 |
| GeneOntologyMolecularFunction | nucleosome binding | H2AZ2 CHD4 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.15e-17 | 98 | 222 | 18 | GO:0031491 |
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.87e-14 | 100 | 222 | 16 | GO:0030527 |
| GeneOntologyMolecularFunction | chromatin DNA binding | H2AZ2 MYOD1 CHD4 H2AC6 H2AC4 H2AC18 H2AC20 NR1H2 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.92e-14 | 167 | 222 | 19 | GO:0031490 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2AZ2 BDKRB2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 SLC51A H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 TENM4 TENM3 H2AC1 AOC3 H2AC7 H2AX H2AZ1 H2AJ | 4.10e-09 | 398 | 222 | 21 | GO:0046982 |
| GeneOntologyMolecularFunction | protein dimerization activity | PDE2A H2AZ2 MYOD1 LHPP IL17D BDKRB2 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST MACROH2A2 SLC51A H2AC12 H2AC11 H3-5 SYNE1 H2AC21 MACROH2A1 XPNPEP1 LCT PDXK TENM4 TENM3 HEY1 H2AC1 GUCY2D AOC3 H2AC7 H2AX H2AZ1 H2AJ RAB11FIP4 MMUT | 1.70e-07 | 1205 | 222 | 35 | GO:0046983 |
| GeneOntologyMolecularFunction | chromatin binding | H2AZ2 MYOD1 CHD4 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 NR1H2 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ GABPA | 2.78e-05 | 739 | 222 | 22 | GO:0003682 |
| GeneOntologyMolecularFunction | interleukin-8 receptor activity | 1.23e-04 | 2 | 222 | 2 | GO:0004918 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.13e-04 | 27 | 222 | 4 | GO:0004112 | |
| GeneOntologyMolecularFunction | interleukin-8 binding | 3.66e-04 | 3 | 222 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity | 3.66e-04 | 3 | 222 | 2 | GO:0004118 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 7.52e-04 | 97 | 222 | 6 | GO:0008081 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 2.59e-11 | 163 | 222 | 16 | GO:0031507 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 CTR9 H2AC1 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 7.70e-11 | 203 | 222 | 17 | GO:0045814 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 CTR9 H2AC1 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 1.17e-07 | 330 | 222 | 17 | GO:0040029 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KNTC1 H2AZ2 ATR CHD4 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 H2AC12 H2AC11 BICRA KMT5A H2AC21 MACROH2A1 HUWE1 SKP1 PARP10 GTF2E1 MTHFR CTR9 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ DOT1L | 3.70e-07 | 999 | 222 | 30 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | H2AZ2 ATR CHD4 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 H2AC12 H2AC11 BICRA KMT5A H2AC21 MACROH2A1 HUWE1 SKP1 PARP10 MTHFR CTR9 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ DOT1L | 4.28e-07 | 896 | 222 | 28 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2AZ2 ATR CHD4 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 BICRA KMT5A H2AC21 MACROH2A1 HUWE1 SKP1 CTR9 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ DOT1L | 4.66e-07 | 741 | 222 | 25 | GO:0006338 |
| GeneOntologyCellularComponent | nucleosome | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.61e-12 | 138 | 229 | 16 | GO:0000786 |
| GeneOntologyCellularComponent | Barr body | 6.98e-05 | 8 | 229 | 3 | GO:0001740 | |
| GeneOntologyCellularComponent | sex chromosome | 1.16e-04 | 44 | 229 | 5 | GO:0000803 | |
| GeneOntologyCellularComponent | X chromosome | 3.42e-04 | 13 | 229 | 3 | GO:0000805 | |
| GeneOntologyCellularComponent | chromatin | H2AZ2 MYOD1 CHD4 FANCD2 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL NR1H2 MACROH2A2 H2AC12 NR1I3 H2AC11 H3-5 BICRA KMT5A H2AC21 MACROH2A1 HEY1 CTR9 H2AC1 BARHL1 H2AC7 H2AX H2AZ1 TSPYL5 DMRTA2 H2AJ GABPA | 3.84e-04 | 1480 | 229 | 31 | GO:0000785 |
| Domain | Histone_H2A | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 4.29e-24 | 23 | 224 | 15 | IPR002119 |
| Domain | H2A | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 4.29e-24 | 23 | 224 | 15 | SM00414 |
| Domain | Histone_H2A_C | H2AZ2 H2AC14 H2AC6 H2AC20 MACROH2A2 H2AC12 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.71e-22 | 17 | 224 | 13 | IPR032454 |
| Domain | Histone_H2A_C | H2AZ2 H2AC14 H2AC6 H2AC20 MACROH2A2 H2AC12 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.71e-22 | 17 | 224 | 13 | PF16211 |
| Domain | HISTONE_H2A | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC21 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.40e-20 | 21 | 224 | 13 | PS00046 |
| Domain | Histone_H2A_CS | H2AZ2 H2AC14 H2AC6 H2AC20 H2AC12 H2AC21 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 7.55e-19 | 15 | 224 | 11 | IPR032458 |
| Domain | Histone_H2A/H2B/H3 | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.91e-18 | 56 | 224 | 16 | IPR007125 |
| Domain | Histone | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.91e-18 | 56 | 224 | 16 | PF00125 |
| Domain | Histone-fold | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.72e-15 | 83 | 224 | 16 | IPR009072 |
| Domain | - | H2AZ2 H2AC14 H2AC6 H2AC20 MACROH2A2 H2AC12 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 7.32e-14 | 69 | 224 | 14 | 1.10.20.10 |
| Domain | ARM-type_fold | RSPH14 RIPOR2 ATR IFT172 PIK3R4 PIK3C2B XPO6 GCN1 TARBP1 FMNL1 DOCK1 TNPO1 RELCH FRYL HUWE1 MROH2B EFR3B AP4B1 | 1.54e-07 | 339 | 224 | 18 | IPR016024 |
| Domain | ARM-like | RSPH14 RIPOR2 ATR PIK3R4 XPO6 GCN1 TARBP1 TNPO1 RELCH FRYL HUWE1 MROH2B EFR3B AP4B1 | 5.05e-06 | 270 | 224 | 14 | IPR011989 |
| Domain | - | RSPH14 RIPOR2 ATR PIK3R4 XPO6 GCN1 TNPO1 RELCH FRYL MROH2B EFR3B AP4B1 | 1.60e-05 | 222 | 224 | 12 | 1.25.10.10 |
| Domain | HEAT_type_2 | 4.24e-05 | 17 | 224 | 4 | IPR021133 | |
| Domain | Chemokine_CXCR_1/2 | 1.43e-04 | 2 | 224 | 2 | IPR000174 | |
| Domain | Core_histone_macro-H2A | 1.43e-04 | 2 | 224 | 2 | IPR021171 | |
| Domain | HEAT_REPEAT | 1.92e-04 | 70 | 224 | 6 | PS50077 | |
| Domain | DUF1220 | 2.62e-04 | 11 | 224 | 3 | PF06758 | |
| Domain | NBPF_dom | 2.62e-04 | 11 | 224 | 3 | IPR010630 | |
| Domain | NBPF | 2.62e-04 | 11 | 224 | 3 | PS51316 | |
| Domain | Rhs_assc_core | 4.26e-04 | 3 | 224 | 2 | IPR022385 | |
| Domain | Tox-GHH_dom | 8.46e-04 | 4 | 224 | 2 | IPR028916 | |
| Domain | Tox-GHH | 8.46e-04 | 4 | 224 | 2 | PF15636 | |
| Domain | Ten_N | 8.46e-04 | 4 | 224 | 2 | IPR009471 | |
| Domain | Ten_N | 8.46e-04 | 4 | 224 | 2 | PF06484 | |
| Domain | TENEURIN_N | 8.46e-04 | 4 | 224 | 2 | PS51361 | |
| Domain | CARD | 8.49e-04 | 16 | 224 | 3 | SM00114 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 5.58e-13 | 139 | 166 | 17 | M4741 |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 H2AX H2AJ | 5.93e-12 | 78 | 166 | 13 | M27234 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 1.03e-11 | 37 | 166 | 10 | M27580 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2AZ2 ATR H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SYNE1 H2AC7 H2AX H2AJ | 1.70e-09 | 78 | 166 | 11 | M1061 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 KMT5A H2AC7 H2AX H2AJ | 1.28e-08 | 73 | 166 | 10 | M27166 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | CHD4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 1.29e-08 | 94 | 166 | 11 | M27230 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | 1.40e-08 | 55 | 166 | 9 | M29526 | |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | 1.68e-08 | 75 | 166 | 10 | M27343 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2AZ2 CHD4 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 KMT5A H2AC21 H2AC1 H2AC7 H2AX H2AJ DOT1L | 2.19e-08 | 272 | 166 | 17 | M29619 |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 3.47e-08 | 29 | 166 | 7 | MM15291 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 4.16e-08 | 62 | 166 | 9 | M27700 | |
| Pathway | REACTOME_DNA_METHYLATION | 5.54e-08 | 64 | 166 | 9 | M27429 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 5.73e-08 | 31 | 166 | 7 | MM17225 | |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | 7.30e-08 | 66 | 166 | 9 | M27488 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 8.35e-08 | 67 | 166 | 9 | M39003 | |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | 8.35e-08 | 67 | 166 | 9 | M27342 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | 9.52e-08 | 68 | 166 | 9 | M27658 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2AZ2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 9.94e-08 | 90 | 166 | 10 | M2158 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.23e-07 | 70 | 166 | 9 | M48028 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | 1.23e-07 | 70 | 166 | 9 | M48261 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.58e-07 | 72 | 166 | 9 | M29714 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.58e-07 | 72 | 166 | 9 | M27132 | |
| Pathway | REACTOME_MEIOSIS | H2AZ2 ATR H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SYNE1 H2AC7 H2AX H2AJ | 1.66e-07 | 120 | 166 | 11 | M529 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 1.84e-07 | 96 | 166 | 10 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 2.04e-07 | 97 | 166 | 10 | M48262 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.12e-07 | 37 | 166 | 7 | MM14883 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.37e-07 | 55 | 166 | 8 | MM14932 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 2.57e-07 | 38 | 166 | 7 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 3.10e-07 | 39 | 166 | 7 | MM14850 | |
| Pathway | REACTOME_UCH_PROTEINASES | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 3.28e-07 | 102 | 166 | 10 | M27576 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 3.56e-07 | 79 | 166 | 9 | M27191 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 3.72e-07 | 40 | 166 | 7 | MM14936 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 4.31e-07 | 105 | 166 | 10 | M27425 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | 5.14e-07 | 107 | 166 | 10 | M48260 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 6.66e-07 | 110 | 166 | 10 | M27696 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 7.35e-07 | 44 | 166 | 7 | MM15527 | |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AZ1 H2AJ | 7.88e-07 | 112 | 166 | 10 | M48334 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 9.03e-07 | 88 | 166 | 9 | M1011 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 9.95e-07 | 89 | 166 | 9 | M27943 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 1.09e-06 | 116 | 166 | 10 | M29806 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | 1.09e-06 | 90 | 166 | 9 | M29668 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | 1.09e-06 | 90 | 166 | 9 | M27691 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.13e-06 | 67 | 166 | 8 | MM15429 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.20e-06 | 91 | 166 | 9 | M27101 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 1.45e-06 | 93 | 166 | 9 | M27487 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 1.73e-06 | 122 | 166 | 10 | M29689 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.80e-06 | 50 | 166 | 7 | MM15308 | |
| Pathway | WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA | 2.07e-06 | 33 | 166 | 6 | M39800 | |
| Pathway | REACTOME_REPRODUCTION | H2AZ2 ATR H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 SYNE1 H2AC7 H2AX H2AJ | 2.62e-06 | 158 | 166 | 11 | M26956 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 3.08e-06 | 54 | 166 | 7 | MM14904 | |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | 3.70e-06 | 104 | 166 | 9 | M29829 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.95e-06 | 56 | 166 | 7 | MM17236 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.33e-06 | 106 | 166 | 9 | M27458 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 5.06e-06 | 108 | 166 | 9 | M27426 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 5.29e-06 | 138 | 166 | 10 | M29805 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 5.89e-06 | 110 | 166 | 9 | M27958 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 6.34e-06 | 111 | 166 | 9 | M27187 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 6.83e-06 | 112 | 166 | 9 | M4052 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 6.83e-06 | 142 | 166 | 10 | M48257 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 KMT5A H2AC7 H2AX H2AJ | 6.83e-06 | 142 | 166 | 10 | M27660 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 6.83e-06 | 142 | 166 | 10 | M27233 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 DTX4 NCSTN SKP1 HEY1 H2AC7 H2AX H2AJ | 6.87e-06 | 246 | 166 | 13 | M10189 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ GREB1 | 1.05e-05 | 149 | 166 | 10 | M27888 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.12e-05 | 119 | 166 | 9 | M607 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.67e-05 | 125 | 166 | 9 | M27186 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 2.02e-05 | 128 | 166 | 9 | M48019 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | 2.15e-05 | 129 | 166 | 9 | M27795 | |
| Pathway | REACTOME_HCMV_INFECTION | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 2.17e-05 | 162 | 166 | 10 | M29804 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 2.57e-05 | 74 | 166 | 7 | MM14605 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KNTC1 ABR H2AZ2 OBSCN CHN1 PIK3R4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 DST FMNL1 MPP7 DOCK1 PLEKHG4 ARHGEF12 H2AC7 H2AX H2AJ ARHGAP18 GARRE1 | 3.78e-05 | 720 | 166 | 22 | M41838 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 3.88e-05 | 139 | 166 | 9 | M868 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.88e-05 | 139 | 166 | 9 | M715 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | CHD4 H2AC6 H2AC4 H2AC18 H2AC20 KMT5A H2AC21 H2AC1 H2AJ DOT1L | 4.21e-05 | 175 | 166 | 10 | MM14941 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 BIRC3 H2AC1 H2AC7 | 6.16e-05 | 221 | 166 | 11 | M27578 |
| Pathway | REACTOME_UCH_PROTEINASES | 7.33e-05 | 87 | 166 | 7 | MM15287 | |
| Pathway | REACTOME_DNA_REPLICATION | 7.37e-05 | 187 | 166 | 10 | M1017 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 1.10e-04 | 159 | 166 | 9 | M27665 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 2.00e-04 | 102 | 166 | 7 | MM15430 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2AZ2 CHD4 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 2.11e-04 | 254 | 166 | 11 | M27131 |
| Pathway | REACTOME_DEUBIQUITINATION | NOD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 BIRC3 H2AC1 H2AC7 | 2.21e-04 | 299 | 166 | 12 | M27574 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ GREB1 | 2.79e-04 | 220 | 166 | 10 | M27794 |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.96e-04 | 114 | 166 | 7 | MM15361 | |
| Pathway | REACTOME_M_PHASE | KNTC1 H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 TNPO1 KMT5A H2AC7 H2AX CEP152 H2AJ ESPL1 | 4.18e-04 | 417 | 166 | 14 | M27662 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2AZ2 H2AC14 DACT1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 4.40e-04 | 233 | 166 | 10 | M27099 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | KNTC1 H2AZ2 PIK3R4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 FMNL1 H2AC7 H2AX H2AJ | 4.45e-04 | 323 | 166 | 12 | M27080 |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 4.61e-04 | 55 | 166 | 5 | M39598 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2AZ2 H2AC14 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 5.03e-04 | 237 | 166 | 10 | M27786 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.13e-04 | 119 | 166 | 7 | MM14901 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.43e-04 | 197 | 166 | 9 | M27188 | |
| Pathway | REACTOME_DNA_REPAIR | H2AZ2 ATR FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC7 H2AX H2AJ | 5.68e-04 | 332 | 166 | 12 | M15434 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 NR1H2 H2AC7 H2AX H2AJ GREB1 | 7.68e-04 | 296 | 166 | 11 | M27869 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.13e-03 | 136 | 166 | 7 | MM14848 | |
| Pathway | SA_CASPASE_CASCADE | 1.35e-03 | 19 | 166 | 3 | M7997 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | IMPDH2 RPN2 SEC24A CHD4 TLR7 NOD2 PIK3R4 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 SKP1 PARP10 GTF2E1 H2AC1 H2AC7 | 1.75e-03 | 888 | 166 | 21 | M48034 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2AZ2 H2AC14 DACT1 H2AC6 H2AC4 H2AC18 H2AC20 SKP1 H2AC7 H2AX H2AJ | 1.84e-03 | 330 | 166 | 11 | M7847 |
| Pathway | REACTOME_INFECTIOUS_DISEASE | IMPDH2 MYO5A RPN2 SEC24A CHD4 TLR7 NOD2 PIK3R4 ADORA2B H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 DOCK1 H2AC11 H2AC21 SKP1 PARP10 GTF2E1 H2AC1 H2AC7 | 1.91e-03 | 1081 | 166 | 24 | M27548 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.91e-03 | 191 | 166 | 8 | MM15289 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 2.09e-03 | 22 | 166 | 3 | M17902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119 | 2.09e-03 | 22 | 166 | 3 | M47924 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.23e-03 | 153 | 166 | 7 | MM15522 | |
| Pubmed | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 9.28e-22 | 74 | 232 | 17 | 36180920 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.27e-20 | 69 | 232 | 16 | 11689053 |
| Pubmed | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.43e-20 | 73 | 232 | 16 | 9566873 | |
| Pubmed | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.43e-20 | 73 | 232 | 16 | 14657027 | |
| Pubmed | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 5.83e-19 | 86 | 232 | 16 | 11080476 | |
| Pubmed | Precise characterization of human histones in the H2A gene family by top down mass spectrometry. | 1.01e-14 | 14 | 232 | 8 | 16457589 | |
| Pubmed | 1.73e-13 | 11 | 232 | 7 | 25362550 | ||
| Pubmed | DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. | 1.73e-13 | 11 | 232 | 7 | 16702407 | |
| Pubmed | 1.73e-13 | 11 | 232 | 7 | 15078818 | ||
| Pubmed | 2.83e-13 | 30 | 232 | 9 | 16319397 | ||
| Pubmed | H2AC14 PARP1 H2AC6 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 H2AX H2AJ | 7.66e-13 | 88 | 232 | 12 | 26318153 | |
| Pubmed | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. | 8.90e-13 | 13 | 232 | 7 | 15823041 | |
| Pubmed | 5.83e-12 | 16 | 232 | 7 | 15386022 | ||
| Pubmed | ABCA2 H2AZ2 IFT172 DHX15 H2AC14 PARP1 H2AC6 H2AC20 DST NBPF14 CCDC136 H2AC12 H2AC21 NBPF15 H2AC1 NBPF9 NBPF10 H2AC7 H2AX H2AZ1 H2AJ TNFAIP2 | 6.62e-12 | 513 | 232 | 22 | 25798074 | |
| Pubmed | Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant. | 1.27e-11 | 5 | 232 | 5 | 11331621 | |
| Pubmed | Phosphorylation of histone H2A inhibits transcription on chromatin templates. | 1.60e-11 | 18 | 232 | 7 | 15010469 | |
| Pubmed | Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers. | 1.70e-11 | 10 | 232 | 6 | 25731851 | |
| Pubmed | Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. | 2.53e-11 | 19 | 232 | 7 | 16359901 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | IMPDH2 ATR RPN2 CHD4 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST SCN5A GCN1 H2AC12 H2AC11 HUWE1 LARP7 H2AC7 H2AJ | 9.31e-11 | 477 | 232 | 20 | 31300519 |
| Pubmed | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 | 1.07e-10 | 77 | 232 | 10 | 12408966 | |
| Pubmed | KNTC1 H2AZ2 ACACB MYO5A MYO5B SPOCK1 RPN2 CHD4 PDE10A H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST H2AC12 H3-5 SYNE1 PPFIA2 GRK5 H2AC21 MACROH2A1 LARP7 PDIA6 SLC25A12 CTR9 H2AC1 H2AC7 H2AX H2AZ1 H2AJ GABPA | 7.04e-10 | 1442 | 232 | 33 | 35575683 | |
| Pubmed | 1.43e-09 | 18 | 232 | 6 | 29743367 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE2A ABCA2 ABR OBSCN FBXL12 LHPP C2CD2L NOD2 DACT1 KMT2C FAT1 DST PIK3C2B XPO6 SCN5A FEM1A GCN1 BICRA GRK5 FRYL TTYH3 HUWE1 PIKFYVE MTHFR USP40 TNFAIP2 DOT1L ESPL1 | 1.73e-09 | 1105 | 232 | 28 | 35748872 |
| Pubmed | Quantitative determination of histone modification. H2A acetylation and phosphorylation. | 1.93e-09 | 4 | 232 | 4 | 7217105 | |
| Pubmed | H2AZ2 IMPDH2 RPN2 DHX15 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 DST GCN1 H2AC12 H2AC11 H3-5 SYNE1 H2AC21 SKP1 PDIA6 H2AC1 PHACTR3 H2AC7 H2AX H2AZ1 H2AJ | 3.01e-09 | 844 | 232 | 24 | 25963833 | |
| Pubmed | 4.12e-09 | 21 | 232 | 6 | 16079250 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 SYNE1 H2AC7 H2AJ | 6.32e-09 | 116 | 232 | 10 | 22810585 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2AZ2 IMPDH2 RPN2 FBXL12 PIK3R4 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 GCN1 HSDL1 H2AC12 H2AC11 H3-5 HUWE1 SKP1 TBL3 PDXK PDIA6 SLC25A12 GTF3C2 CTR9 H2AC7 H2AX H2AZ1 H2AJ | 7.03e-09 | 1257 | 232 | 29 | 37317656 |
| Pubmed | 9.60e-09 | 5 | 232 | 4 | 35072799 | ||
| Pubmed | 2.86e-08 | 6 | 232 | 4 | 15509584 | ||
| Pubmed | Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. | 6.65e-08 | 7 | 232 | 4 | 16699504 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 ABR MYO5A PLCXD1 INSR OBSCN LHPP ATP8B1 PDE10A ITPKB KMT2C PTPRB SLC9A7 MACROH2A2 ZSWIM4 DOCK1 DIP2B BICRA PPFIA2 MACROH2A1 FRYL TTYH3 HUWE1 PDXK PARP10 USP40 GREB1 HPS5 TATDN1 FGGY | 7.68e-08 | 1489 | 232 | 30 | 28611215 |
| Pubmed | 8.30e-08 | 55 | 232 | 7 | 9439656 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 H2AZ2 SPOCK1 RPN2 ACO1 CHD4 DHX15 PARP1 DST TONSL GCN1 H2AC12 SYNE1 XPNPEP1 HUWE1 PDIA6 H2AC1 SMS ARHGAP18 MYO16 ALG13 | 1.36e-07 | 807 | 232 | 21 | 30575818 |
| Pubmed | MYO5A MYO5B RPN2 SEC24A FBXL12 FANCD2 FBXO38 PARP1 PTPRB PTPRZ1 MACROH2A2 DCTPP1 GCN1 MPP7 RELCH PSTPIP2 HUWE1 SKP1 PTPN5 GTF2E1 PDIA6 CTR9 EFR3B UBR3 | 1.79e-07 | 1049 | 232 | 24 | 27880917 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | EFS KIAA0586 DHX15 FAT1 NBPF14 XPNPEP1 HUWE1 DNAH7 NBPF9 NBPF10 | 2.40e-07 | 170 | 232 | 10 | 23314748 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | H2AZ2 MYO5A ACO1 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 MGAM MXRA8 H2AC21 LAMP2 MACROH2A1 TTYH3 XPNPEP1 LBP H2AC1 H2AC7 H2AX H2AZ1 SMS H2AJ | 2.56e-07 | 1070 | 232 | 24 | 23533145 |
| Pubmed | H2AZ2 RPN2 CHD4 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DDX46 H2AC12 H2AC11 H2AC21 NCSTN SKP1 DNAH7 LARP7 PDIA6 CTR9 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.66e-07 | 1153 | 232 | 25 | 29845934 | |
| Pubmed | 2.93e-07 | 3 | 232 | 3 | 20943707 | ||
| Pubmed | H2AZ2 H2AC6 H2AC4 H2AC18 H2AC20 DST H2AC11 SYNE1 H2AC21 MACROH2A1 PDXK H2AC1 H2AC7 H2AX H2AZ1 | 3.05e-07 | 438 | 232 | 15 | 21630459 | |
| Pubmed | 3.93e-07 | 10 | 232 | 4 | 23384561 | ||
| Pubmed | H2AZ2 IMPDH2 RPN2 FANCD2 DHX15 H2AC14 PARP1 GCN1 TNPO1 SYNE1 MACROH2A1 HUWE1 TBL3 PDIA6 CTR9 | 6.14e-07 | 463 | 232 | 15 | 34901782 | |
| Pubmed | 9.16e-07 | 12 | 232 | 4 | 15525528 | ||
| Pubmed | 9.16e-07 | 12 | 232 | 4 | 14759373 | ||
| Pubmed | H2AC6 H2AC4 H2AC18 H2AC20 PPFIA2 H2AC21 UFL1 PDIA6 TENM3 H2AX H2AJ | 9.65e-07 | 247 | 232 | 11 | 30713523 | |
| Pubmed | Histone H2A variants alpha1-extension helix directs RNF168-mediated ubiquitination. | 1.17e-06 | 4 | 232 | 3 | 32424115 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 IMPDH2 ATR RPN2 KIAA0586 CHD4 RPRD1B FANCD2 PIK3R4 DHX15 PARP1 GCN1 TNPO1 SYNE1 H2AC21 BIRC3 UFL1 MACROH2A1 HUWE1 TBL3 PDXK LARP7 PDIA6 GTF3C2 CTR9 H2AC7 H2AZ1 | 1.18e-06 | 1425 | 232 | 27 | 30948266 |
| Pubmed | 1.32e-06 | 13 | 232 | 4 | 31624230 | ||
| Pubmed | ABR IMPDH2 RPN2 SEC24A MPDZ DHX15 PARP1 DST GCN1 MPP7 DOCK1 TNPO1 ARHGEF12 LAMP2 XPNPEP1 PDIA6 SH3D19 EFR3B | 1.53e-06 | 708 | 232 | 18 | 39231216 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H2AZ2 IMPDH2 MYO5A MYO5B INSR CHD4 DHX15 PARP1 H2AC18 DDX46 DST MACROH2A2 GCN1 TNPO1 SYNE1 H2AC21 UFL1 MACROH2A1 HUWE1 TBL3 PDIA6 H2AC1 | 1.68e-06 | 1024 | 232 | 22 | 24711643 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 H2AZ2 IMPDH2 ACO1 SEC24A RPRD1B FANCD2 DHX15 H2AC4 DCTPP1 GCN1 TNPO1 H2AC11 RELCH COG7 LAMP2 FRYL XPNPEP1 HUWE1 LARP7 GTF2E1 PDIA6 CTR9 H2AZ1 SMS TATDN1 GABPA | 1.75e-06 | 1455 | 232 | 27 | 22863883 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ACACB RPN2 FANCD2 H2AC4 H2AC20 GCN1 H2AC12 MPP7 SYNE1 PPFIA2 H2AC21 SKP1 LARP7 PTPN5 PDIA6 PHACTR3 | 1.80e-06 | 573 | 232 | 16 | 28330616 |
| Pubmed | IMPDH2 ATR RPN2 MPDZ PIK3R4 PHKA2 DST TONSL HSDL1 DIP2B RGS3 PDIA6 CTR9 TNFAIP2 AP4B1 HPS5 GARRE1 | 2.06e-06 | 650 | 232 | 17 | 38777146 | |
| Pubmed | 2.20e-06 | 32 | 232 | 5 | 30532072 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | PDE10A BDKRB2 PTPRB PTPRZ1 GRK5 MACROH2A1 ADAMTS13 GUCY2D MYO16 | 2.44e-06 | 171 | 232 | 9 | 20201926 |
| Pubmed | IMPDH2 MYO5A RPRD1B DHX15 PARP1 H2AC6 DDX46 DST MACROH2A2 H2AC12 H2AC21 MACROH2A1 SKP1 TBL3 CTR9 H2AX H2AZ1 | 2.53e-06 | 660 | 232 | 17 | 32780723 | |
| Pubmed | IMPDH2 ATR CHD4 RPRD1B FANCD2 DHX15 PARP1 H2AC4 DDX46 H2AC12 TNPO1 UFL1 MACROH2A1 TBL3 PDXK LARP7 GTF2E1 GTF3C2 CTR9 H2AZ1 SMS | 5.13e-06 | 1014 | 232 | 21 | 32416067 | |
| Pubmed | Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8 macrodomains. | 5.77e-06 | 6 | 232 | 3 | 23473667 | |
| Pubmed | 5.87e-06 | 67 | 232 | 6 | 25253489 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 ACACB OBSCN PIK3R4 KMT2C DDX46 PTPRB PIK3C2B CASP9 MACROH2A1 SKP1 VPS13D RPIA SLC25A12 | 7.31e-06 | 497 | 232 | 14 | 36774506 |
| Pubmed | H2AZ2 DHX15 PARP1 H2AC6 H2AC18 H2AC20 H2AC12 CASP9 H2AC7 H2AJ | 7.81e-06 | 250 | 232 | 10 | 33536335 | |
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 16059920 | ||
| Pubmed | RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. | 1.01e-05 | 7 | 232 | 3 | 22980979 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.01e-05 | 7 | 232 | 3 | 8858345 | |
| Pubmed | RIPOR2 IMPDH2 MPDZ CHD4 KMT2C H2AC6 DST PDIA6 LIPE TENM3 ESPL1 | 1.22e-05 | 322 | 232 | 11 | 26514267 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.34e-05 | 211 | 232 | 9 | 17314511 | |
| Pubmed | Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. | 1.35e-05 | 116 | 232 | 7 | 37117180 | |
| Pubmed | ABCA2 KMT2C DDX46 DST MRC2 RELCH RNF44 UFL1 NCSTN GTF3C2 EFR3B HPS5 ESPL1 GARRE1 | 1.47e-05 | 529 | 232 | 14 | 14621295 | |
| Pubmed | 1.60e-05 | 8 | 232 | 3 | 29985131 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | IMPDH2 RPN2 ACO1 CHD4 RPRD1B DHX15 PARP1 H2AC4 H2AC18 DDX46 MRC2 GCN1 TNPO1 H2AC11 LAMP2 MACROH2A1 FRYL TTYH3 XPNPEP1 HUWE1 PARP10 H2AZ1 TSPYL5 MMUT | 1.69e-05 | 1367 | 232 | 24 | 32687490 |
| Pubmed | DCHS2 PDE2A ABCA2 MYO5A ADAM23 ACO1 IFT172 CHD4 SYNC PIK3R4 PARP1 DST NECAB1 LRRN2 NR1H2 TARBP1 SYNE1 HUWE1 IDS HEY1 CTR9 SH3D19 RAB11FIP4 | 1.90e-05 | 1285 | 232 | 23 | 35914814 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | IFT172 MPDZ DDX46 MACROH2A2 FMNL1 DIP2B GRK5 ARHGEF12 UFL1 MACROH2A1 SKP1 LARP7 TENM4 | 2.10e-05 | 475 | 232 | 13 | 31040226 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H2AZ2 MYO5A CHD4 DHX15 H2AC14 PARP1 H2AC18 H2AC20 DDX46 DST H2AC12 H2AC11 H3-5 SYNE1 MACROH2A1 TBL3 H2AC7 H2AZ1 H2AJ | 2.33e-05 | 949 | 232 | 19 | 36574265 |
| Pubmed | The genomic organization of the histone clusters on human 6p21.3. | 2.39e-05 | 9 | 232 | 3 | 10384058 | |
| Pubmed | 2.66e-05 | 87 | 232 | 6 | 12465718 | ||
| Pubmed | 2.83e-05 | 130 | 232 | 7 | 12421765 | ||
| Pubmed | IMPDH2 RPN2 CHD4 FANCD2 H2AC14 H2AC6 H2AC4 GCN1 H2AC12 H2AC11 H2AC21 HUWE1 PDIA6 SLC25A12 H2AC1 H2AC7 H2AX H2AJ | 2.83e-05 | 878 | 232 | 18 | 37223481 | |
| Pubmed | RPN2 IFT172 CHD4 DHX15 H2AC14 PARP1 DDX46 GCN1 TNPO1 COG7 UFL1 HUWE1 TBL3 PDIA6 CTR9 | 2.88e-05 | 638 | 232 | 15 | 33239621 | |
| Pubmed | 2.93e-05 | 233 | 232 | 9 | 37704626 | ||
| Pubmed | TRAIP regulates replication fork recovery and progression via PCNA. | 3.00e-05 | 27 | 232 | 4 | 27462463 | |
| Pubmed | 3.00e-05 | 27 | 232 | 4 | 11156964 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RPN2 IFT172 FBXL12 MPDZ FANCD2 CORO7 DCTPP1 GCN1 MPP7 TNPO1 DIP2B NCSTN PSTPIP2 HUWE1 PTPN5 PDIA6 CTR9 SMS ESPL1 | 3.32e-05 | 974 | 232 | 19 | 28675297 |
| Pubmed | 3.40e-05 | 10 | 232 | 3 | 21726816 | ||
| Pubmed | 3.40e-05 | 10 | 232 | 3 | 26751069 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 3.40e-05 | 10 | 232 | 3 | 22973535 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ACACB ATR CHD4 SASH3 GCN1 FMNL1 TNPO1 TBL3 GTF2E1 GTF3C2 H2AX | 4.34e-05 | 370 | 232 | 11 | 22922362 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | IMPDH2 SPOCK1 RPN2 CHD4 DHX15 PARP1 DDX46 DST MACROH2A2 GCN1 HSDL1 TNPO1 DIP2B SYNE1 UFL1 MACROH2A1 SKP1 PDIA6 SLC25A12 TSPYL5 | 4.35e-05 | 1082 | 232 | 20 | 38697112 |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 16987681 | ||
| Pubmed | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. | 4.43e-05 | 2 | 232 | 2 | 20044480 | |
| Pubmed | A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. | 4.43e-05 | 2 | 232 | 2 | 19680243 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 26565020 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 16909103 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 22171941 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 26087179 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 34730557 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 19513550 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 17322296 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 28714367 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21555225 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21254176 | ||
| Interaction | H2BC26 interactions | FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 H2AC12 H2AC11 H2AC21 UFL1 MACROH2A1 HUWE1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.70e-15 | 183 | 226 | 21 | int:H2BC26 |
| Interaction | H2AC7 interactions | H2AZ2 FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H3-5 H2AC21 BIRC3 MACROH2A1 LARP7 H2AC1 H2AC7 H2AJ | 3.64e-15 | 107 | 226 | 17 | int:H2AC7 |
| Interaction | LOC102724334 interactions | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 TARBP1 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.16e-14 | 134 | 226 | 18 | int:LOC102724334 |
| Interaction | H2AC1 interactions | FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC21 LARP7 H2AC1 H2AC7 H2AX H2AJ DOT1L | 4.54e-14 | 71 | 226 | 14 | int:H2AC1 |
| Interaction | H2AC6 interactions | FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H3-5 H2AC21 LARP7 H2AC1 H2AC7 H2AZ1 H2AJ | 3.82e-13 | 100 | 226 | 15 | int:H2AC6 |
| Interaction | H2BC15 interactions | FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 BIRC3 MACROH2A1 LARP7 H2AC1 H2AC7 H2AX H2AJ | 5.64e-13 | 144 | 226 | 17 | int:H2BC15 |
| Interaction | H2AJ interactions | H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DDX46 TONSL H2AC12 H3-5 H2AC21 MACROH2A1 LARP7 H2AC1 H2AC7 H2AJ | 9.98e-13 | 127 | 226 | 16 | int:H2AJ |
| Interaction | H2AC13 interactions | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H3-5 KMT5A H2AC21 MACROH2A1 H2AC1 H2AC7 H2AJ | 2.15e-12 | 75 | 226 | 13 | int:H2AC13 |
| Interaction | H3C15 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 UFL1 H2AC7 H2AX H2AZ1 H2AJ | 2.27e-12 | 207 | 226 | 19 | int:H3C15 |
| Interaction | H2BC11 interactions | H2AZ2 FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.58e-12 | 186 | 226 | 18 | int:H2BC11 |
| Interaction | H2AC12 interactions | CHD4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 LARP7 H2AC1 H2AC7 H2AJ | 4.56e-12 | 118 | 226 | 15 | int:H2AC12 |
| Interaction | H2BC12 interactions | H2AZ2 CHD4 RPRD1B FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 DST MACROH2A2 H2AC12 H2AC11 H3-5 MACROH2A1 HUWE1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.48e-11 | 322 | 226 | 22 | int:H2BC12 |
| Interaction | H2BC18 interactions | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 PIK3C2B H2AC12 H2AC11 H2AC21 UFL1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.15e-11 | 180 | 226 | 17 | int:H2BC18 |
| Interaction | H2BC5 interactions | H2AZ2 CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST H2AC12 H2AC11 H3-5 H2AC21 UFL1 HUWE1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 2.54e-11 | 331 | 226 | 22 | int:H2BC5 |
| Interaction | H3-5 interactions | H2AZ2 CHD4 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H3-5 H2AC7 H2AX H2AJ | 3.86e-11 | 114 | 226 | 14 | int:H3-5 |
| Interaction | H2BC17 interactions | H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 5.55e-11 | 140 | 226 | 15 | int:H2BC17 |
| Interaction | H2AC14 interactions | FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H3-5 H2AC21 MACROH2A1 LARP7 H2AC1 H2AC7 H2AJ | 8.33e-11 | 144 | 226 | 15 | int:H2AC14 |
| Interaction | H2BC3 interactions | CHD4 RPRD1B FANCD2 H2AC14 KMT2C PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H2AC21 MACROH2A1 SKP1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ DOT1L | 2.14e-10 | 406 | 226 | 23 | int:H2BC3 |
| Interaction | H4C9 interactions | CHD4 PARP1 H2AC20 TONSL MACROH2A2 H2AC11 KMT5A H2AC21 MACROH2A1 LARP7 H2AX H2AZ1 TSPYL5 | 2.53e-10 | 108 | 226 | 13 | int:H4C9 |
| Interaction | MCM5 interactions | H2AZ2 FANCD2 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC12 WDR62 H2AC11 H3-5 H2AC21 BIRC3 UFL1 HUWE1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 4.16e-10 | 420 | 226 | 23 | int:MCM5 |
| Interaction | H2AC4 interactions | ACO1 CHD4 FANCD2 H2AC14 KMT2C PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC12 H2AC11 H3-5 H2AC21 UFL1 MACROH2A1 SKP1 LARP7 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ | 5.92e-10 | 506 | 226 | 25 | int:H2AC4 |
| Interaction | H2BC21 interactions | OBSCN CHD4 RPRD1B C2CD2L DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 SASH3 MACROH2A2 H2AC12 TNPO1 H2AC11 H3-5 H2AC21 UFL1 MACROH2A1 HUWE1 LARP7 PARP10 CTR9 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 1.21e-09 | 696 | 226 | 29 | int:H2BC21 |
| Interaction | H2AC18 interactions | H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H3-5 MACROH2A1 LARP7 H2AC1 H2AC7 H2AJ | 1.30e-09 | 148 | 226 | 14 | int:H2AC18 |
| Interaction | H3-4 interactions | H2AZ2 CHD4 FANCD2 H2AC14 KMT2C PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC12 TNPO1 H2AC11 H3-5 H2AC21 BIRC3 MACROH2A1 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 1.45e-09 | 448 | 226 | 23 | int:H3-4 |
| Interaction | H2BC1 interactions | H2AZ2 CHD4 PARP1 H2AC6 H2AC4 H2AC20 TONSL MACROH2A2 H2AC11 H2AC21 MACROH2A1 LARP7 H2AC1 H2AX H2AZ1 | 1.66e-09 | 178 | 226 | 15 | int:H2BC1 |
| Interaction | H2BC13 interactions | H2AZ2 CHD4 FANCD2 H2AC6 H2AC4 H2AC18 DST TONSL H2AC11 H3-5 LARP7 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 2.05e-09 | 210 | 226 | 16 | int:H2BC13 |
| Interaction | H2AC25 interactions | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H3-5 LARP7 H2AC1 H2AC7 H2AJ | 2.50e-09 | 84 | 226 | 11 | int:H2AC25 |
| Interaction | H2AC20 interactions | STK17B CHD4 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 TONSL H2AC12 H2AC11 H3-5 MACROH2A1 LARP7 PARP10 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.99e-09 | 320 | 226 | 19 | int:H2AC20 |
| Interaction | H1-0 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 MACROH2A2 H2AC12 H3-5 DET1 KMT5A H2AC21 BIRC3 UFL1 MACROH2A1 H2AZ1 H2AJ | 5.13e-09 | 256 | 226 | 17 | int:H1-0 |
| Interaction | H3C1 interactions | H2AZ2 MYOD1 CHD4 FANCD2 H2AC14 KMT2C PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 TARBP1 H2AC12 H2AC11 H3-5 KMT5A SYNE1 H2AC21 MACROH2A1 LARP7 PIKFYVE PARP10 GTF2E1 GTF3C2 CTR9 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ | 7.71e-09 | 901 | 226 | 32 | int:H3C1 |
| Interaction | H2AC21 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 MACROH2A2 H2AC12 H2AC21 BIRC3 LARP7 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 9.71e-09 | 234 | 226 | 16 | int:H2AC21 |
| Interaction | H3-3A interactions | CHD4 FANCD2 FBXO38 H2AC14 KMT2C PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 TNPO1 H2AC11 H3-5 KMT5A BIRC3 UFL1 MACROH2A1 PARP10 GTF2E1 GTF3C2 PHACTR3 H2AC7 H2AX TSPYL5 H2AJ DOT1L GABPA | 2.49e-08 | 749 | 226 | 28 | int:H3-3A |
| Interaction | H2BC4 interactions | H2AZ2 RPRD1B KMT2C PARP1 H2AC6 H2AC4 H2AC18 MACROH2A2 H2AC12 H2AC11 MACROH2A1 HUWE1 LARP7 H2AC7 H2AX H2AZ1 | 4.05e-08 | 259 | 226 | 16 | int:H2BC4 |
| Interaction | XPC interactions | IMPDH2 ATR PARP1 H2AC4 H2AC20 MACROH2A2 H2AC11 H2AC21 MACROH2A1 LARP7 H2AX H2AZ1 DOT1L | 5.75e-08 | 168 | 226 | 13 | int:XPC |
| Interaction | HMGA1 interactions | ACACB INSR CHD4 FANCD2 FBXO38 PARP1 H2AC6 H2AC4 H2AC18 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 RGS3 CTR9 H2AX H2AZ1 DOT1L | 5.99e-08 | 419 | 226 | 20 | int:HMGA1 |
| Interaction | HNRNPD interactions | OBSCN CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 TARBP1 H2AC12 TNPO1 H2AC11 COG7 H2AC21 BIRC3 UFL1 LARP7 HEY1 H2AC1 H2AC7 H2AX H2AJ DOT1L ESPL1 | 6.05e-08 | 638 | 226 | 25 | int:HNRNPD |
| Interaction | H3C2 interactions | PARP1 H2AC20 TONSL MACROH2A2 H2AC11 H2AC21 MACROH2A1 H2AX H2AZ1 | 6.64e-08 | 68 | 226 | 9 | int:H3C2 |
| Interaction | RNF168 interactions | RPRD1B DHX15 PARP1 H2AC4 H2AC18 H2AC20 KMT5A MACROH2A1 H2AX H2AZ1 | 1.53e-07 | 98 | 226 | 10 | int:RNF168 |
| Interaction | MIER3 interactions | 1.60e-07 | 23 | 226 | 6 | int:MIER3 | |
| Interaction | MCM2 interactions | H2AZ2 IMPDH2 ATR RPN2 CHD4 FANCD2 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST TONSL MACROH2A2 GCN1 H2AC12 H2AC11 RELCH SYNE1 H2AC21 BIRC3 HUWE1 SKP1 PDIA6 GTF3C2 H2AC1 PHACTR3 H2AC7 H2AX H2AZ1 H2AJ | 1.61e-07 | 1081 | 226 | 33 | int:MCM2 |
| Interaction | PPM1G interactions | H2AZ2 RPN2 FANCD2 FBXO38 PARP1 H2AC4 H2AC18 H2AC20 DDX46 MACROH2A2 H2AC12 H2AC21 HUWE1 LARP7 H2AX H2AZ1 H2AJ | 1.69e-07 | 325 | 226 | 17 | int:PPM1G |
| Interaction | H3C14 interactions | CHD4 KMT2C H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 MACROH2A1 H2AC7 H2AX H2AZ1 DOT1L | 2.01e-07 | 156 | 226 | 12 | int:H3C14 |
| Interaction | PRKCB interactions | H2AZ2 IMPDH2 SEC24A FANCD2 H2AC14 H2AC6 H2AC20 DDX46 H2AC12 HUWE1 H2AC7 H2AX H2AZ1 H2AJ ACSL5 | 2.05e-07 | 255 | 226 | 15 | int:PRKCB |
| Interaction | MACROH2A1 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 H2AC12 TNPO1 H2AC11 BIRC3 MACROH2A1 HUWE1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ | 2.51e-07 | 458 | 226 | 20 | int:MACROH2A1 |
| Interaction | NPTN interactions | KNTC1 ATR FBXL12 FANCD2 XPO6 TONSL GCN1 TARBP1 SEC14L1 TNPO1 PLEKHG4 COG7 HUWE1 PIKFYVE TNFAIP2 | 6.19e-07 | 278 | 226 | 15 | int:NPTN |
| Interaction | SUPT16H interactions | CHD4 FANCD2 DHX15 PARP1 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 FMNL1 H3-5 BIRC3 UFL1 MACROH2A1 NCSTN CTR9 H2AX H2AZ1 H2AJ | 6.44e-07 | 442 | 226 | 19 | int:SUPT16H |
| Interaction | NEK4 interactions | ABCA2 H2AZ2 IFT172 DHX15 H2AC14 PARP1 H2AC6 H2AC20 DST NBPF14 CCDC136 H2AC12 H2AC21 NBPF15 H2AC1 NBPF9 NBPF10 H2AC7 H2AX H2AZ1 H2AJ TNFAIP2 | 7.21e-07 | 582 | 226 | 22 | int:NEK4 |
| Interaction | H2BC9 interactions | H2AZ2 CHD4 ADGRG4 H2AC14 PARP1 H2AC4 H2AC18 H2AC20 DST H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 LARP7 H2AC7 H2AX H2AZ1 CFAP44 | 7.37e-07 | 446 | 226 | 19 | int:H2BC9 |
| Interaction | H2AC11 interactions | CHD4 H2AC4 H2AC18 H2AC20 DST MACROH2A2 H2AC12 H2AC11 UFL1 MACROH2A1 LARP7 H2AC7 H2AX H2AZ1 | 8.64e-07 | 248 | 226 | 14 | int:H2AC11 |
| Interaction | APLF interactions | 8.73e-07 | 47 | 226 | 7 | int:APLF | |
| Interaction | H1-1 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H2AC11 H3-5 DET1 H2AC21 MACROH2A1 LARP7 CTR9 H2AC7 H2AX H2AZ1 DOT1L | 1.23e-06 | 507 | 226 | 20 | int:H1-1 |
| Interaction | HMGN2 interactions | H2AZ2 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 MACROH2A2 H2AC12 H2AC11 KMT5A SYNE1 MACROH2A1 | 1.43e-06 | 222 | 226 | 13 | int:HMGN2 |
| Interaction | HMGN4 interactions | FANCD2 H2AC14 PARP1 H2AC20 MACROH2A2 H2AC11 H2AC21 MACROH2A1 H2AZ1 | 1.88e-06 | 100 | 226 | 9 | int:HMGN4 |
| Interaction | HSD3B2 interactions | 2.98e-06 | 21 | 226 | 5 | int:HSD3B2 | |
| Interaction | SSRP1 interactions | CHD4 RPRD1B FANCD2 H2AC14 PARP1 H2AC4 H2AC18 H2AC20 TONSL MACROH2A2 FMNL1 H2AC11 H2AC21 BIRC3 UFL1 NCSTN HUWE1 LARP7 CTR9 H2AX H2AZ1 H2AJ DOT1L | 2.99e-06 | 685 | 226 | 23 | int:SSRP1 |
| Interaction | H2AZ2 interactions | H2AZ2 RPN2 CHD4 FANCD2 TARBP1 H3-5 XPNPEP1 HUWE1 LARP7 H2AC7 H2AZ1 | 3.19e-06 | 168 | 226 | 11 | int:H2AZ2 |
| Interaction | H2AZ1 interactions | H2AZ2 STK17B CHD4 PARP1 H2AC6 H2AC4 H2AC20 MACROH2A2 TARBP1 H2AC11 H2AC21 BIRC3 MACROH2A1 LARP7 H2AX H2AZ1 | 4.86e-06 | 371 | 226 | 16 | int:H2AZ1 |
| Interaction | HP1BP3 interactions | CHD4 FANCD2 PARP1 H2AC4 H2AC20 PTPRB H2AC12 H3-5 UFL1 LAMP2 HUWE1 LARP7 H2AZ1 TSPYL5 DOT1L | 4.97e-06 | 329 | 226 | 15 | int:HP1BP3 |
| Interaction | H3C11 interactions | 5.19e-06 | 40 | 226 | 6 | int:H3C11 | |
| Interaction | H2BC10 interactions | 5.30e-06 | 61 | 226 | 7 | int:H2BC10 | |
| Interaction | NUMA1 interactions | IMPDH2 MYO5B CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 MACROH2A2 H2AC21 BIRC3 MACROH2A1 NCSTN H2AC7 H2AX H2AZ1 SMS | 6.25e-06 | 469 | 226 | 18 | int:NUMA1 |
| Interaction | H1-2 interactions | CHD4 FANCD2 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 DST TONSL FMNL1 H2AC12 H2AC11 H3-5 H2AC21 BIRC3 MACROH2A1 LARP7 CTR9 H2AC7 H2AX H2AZ1 DOT1L | 6.43e-06 | 666 | 226 | 22 | int:H1-2 |
| Interaction | H2BC20P interactions | 6.97e-06 | 42 | 226 | 6 | int:H2BC20P | |
| Interaction | MEPCE interactions | H2AZ2 RPN2 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 DOCK1 H2AC11 H2AC21 UFL1 NCSTN SKP1 LARP7 PDIA6 H2AC1 H2AC7 H2AX H2AZ1 TSPYL5 H2AJ DOT1L | 1.32e-05 | 859 | 226 | 25 | int:MEPCE |
| Interaction | GPR17 interactions | KNTC1 ATR STK17B FANCD2 PIK3R4 XPO6 TONSL TARBP1 COG7 UFL1 TTYH3 UBR3 TNFAIP2 | 1.99e-05 | 283 | 226 | 13 | int:GPR17 |
| Interaction | TONSL interactions | 2.26e-05 | 104 | 226 | 8 | int:TONSL | |
| Interaction | SIRT6 interactions | IMPDH2 CHD4 RPRD1B PARP1 H2AC4 H2AC20 FAT1 TONSL H2AC12 H2AC11 H2AC21 MACROH2A1 HUWE1 TBL3 PCDH20 LARP7 GTF3C2 CTR9 H2AZ1 ESPL1 | 2.90e-05 | 628 | 226 | 20 | int:SIRT6 |
| Interaction | H4C2 interactions | 3.07e-05 | 54 | 226 | 6 | int:H4C2 | |
| Interaction | H2AC8 interactions | IMPDH2 PARP1 TONSL MACROH2A2 H2AC11 H2AC21 MACROH2A1 HUWE1 LARP7 H2AZ1 | 3.24e-05 | 177 | 226 | 10 | int:H2AC8 |
| Interaction | PBRM1 interactions | MYOD1 CHD4 FANCD2 PARP1 H2AC4 H2AC20 BICRA BIRC3 MACROH2A1 H2AX H2AZ1 DOT1L | 3.68e-05 | 258 | 226 | 12 | int:PBRM1 |
| Interaction | NAP1L1 interactions | FANCD2 PARP1 H2AC4 H2AC20 H2AC11 H2AC21 BIRC3 UFL1 MACROH2A1 HUWE1 LARP7 H2AX H2AZ1 DOT1L | 3.76e-05 | 345 | 226 | 14 | int:NAP1L1 |
| Interaction | H3-3B interactions | 4.39e-05 | 114 | 226 | 8 | int:H3-3B | |
| Interaction | MCM4 interactions | CHD4 FANCD2 PARP1 H2AC4 TONSL MACROH2A2 RELCH BIRC3 UFL1 HUWE1 GTF3C2 H2AX CEP152 | 4.47e-05 | 306 | 226 | 13 | int:MCM4 |
| Interaction | MYSM1 interactions | 4.63e-05 | 58 | 226 | 6 | int:MYSM1 | |
| Interaction | H3C6 interactions | CHD4 FANCD2 PARP1 H2AC4 H2AC20 TONSL H2AC11 H2AC21 MACROH2A1 GTF3C2 H2AC1 | 5.16e-05 | 226 | 226 | 11 | int:H3C6 |
| Interaction | H1-4 interactions | H2AZ2 CHD4 FANCD2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 FMNL1 H2AC12 H2AC11 H3-5 H2AC21 UFL1 MACROH2A1 LARP7 CTR9 H2AC7 H2AX DOT1L | 5.33e-05 | 656 | 226 | 20 | int:H1-4 |
| Interaction | H1-6 interactions | H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 H3-5 H2AC21 LARP7 H2AC7 H2AX | 5.82e-05 | 229 | 226 | 11 | int:H1-6 |
| Interaction | GPR182 interactions | KNTC1 ABCA2 ATR RPN2 FANCD2 PIK3R4 XPO6 TONSL GCN1 TARBP1 SEC14L1 RELCH PLEKHG4 UFL1 LIPE TNFAIP2 | 5.91e-05 | 455 | 226 | 16 | int:GPR182 |
| Interaction | RBX1 interactions | H2AZ2 ACACB MYO5A MYO5B FBXL12 FANCD2 DHX15 FBXO38 PARP1 H2AC6 CORO7 DET1 KMT5A GRK5 H2AC21 MACROH2A1 SKP1 H2AX | 6.24e-05 | 558 | 226 | 18 | int:RBX1 |
| Interaction | SMARCB1 interactions | MYO5B MYOD1 CHD4 KMT2C PARP1 H2AC4 BICRA ARHGEF12 MACROH2A1 NCSTN GTF2E1 H2AX H2AZ1 DOT1L | 6.70e-05 | 364 | 226 | 14 | int:SMARCB1 |
| Interaction | H2BC6 interactions | 6.77e-05 | 62 | 226 | 6 | int:H2BC6 | |
| Interaction | BAZ1A interactions | 6.85e-05 | 156 | 226 | 9 | int:BAZ1A | |
| Interaction | PHKG2 interactions | 7.40e-05 | 91 | 226 | 7 | int:PHKG2 | |
| Interaction | XRCC5 interactions | ATR MPDZ CHD4 FANCD2 PARP1 H2AC4 TONSL FMNL1 GRK5 BIRC3 UFL1 MACROH2A1 HUWE1 LARP7 H2AX H2AZ1 DOT1L | 7.57e-05 | 515 | 226 | 17 | int:XRCC5 |
| Interaction | ELK4 interactions | 7.93e-05 | 92 | 226 | 7 | int:ELK4 | |
| Interaction | H1-10 interactions | CHD4 FANCD2 H2AC14 H2AC4 H2AC12 H2AC11 KMT5A H2AC21 BIRC3 UFL1 LARP7 DOT1L | 8.08e-05 | 280 | 226 | 12 | int:H1-10 |
| Interaction | PINK1 interactions | IMPDH2 ATR RPN2 CHD4 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DST SCN5A GCN1 H2AC12 H2AC11 HUWE1 LARP7 H2AC7 H2AJ | 8.54e-05 | 679 | 226 | 20 | int:PINK1 |
| Interaction | GTF3C1 interactions | CHN1 DHX15 PARP1 H2AC4 BIRC3 UFL1 MACROH2A1 NCSTN GTF3C2 H2AX DOT1L | 9.19e-05 | 241 | 226 | 11 | int:GTF3C1 |
| Interaction | OVOL2 interactions | 9.43e-05 | 127 | 226 | 8 | int:OVOL2 | |
| Interaction | RP2 interactions | 9.73e-05 | 95 | 226 | 7 | int:RP2 | |
| Interaction | HEXIM1 interactions | H2AZ2 RPN2 CHD4 DHX15 H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H2AC21 SKP1 DNAH7 LARP7 PDIA6 H2AC1 H2AC7 H2AX H2AZ1 H2AJ DOT1L | 9.84e-05 | 913 | 226 | 24 | int:HEXIM1 |
| Interaction | PSIP1 interactions | CHD4 FANCD2 PARP1 BIRC3 UFL1 MACROH2A1 NCSTN H2AX H2AZ1 DOT1L | 1.11e-04 | 205 | 226 | 10 | int:PSIP1 |
| Interaction | HMGN1 interactions | 1.21e-04 | 168 | 226 | 9 | int:HMGN1 | |
| Interaction | MMS22L interactions | 1.24e-04 | 69 | 226 | 6 | int:MMS22L | |
| Interaction | CETN2 interactions | 1.30e-04 | 133 | 226 | 8 | int:CETN2 | |
| Interaction | H2AX interactions | ATR RPN2 CHD4 FANCD2 PARP1 H2AC4 H2AC20 TONSL H2AC11 H3-5 H2AC21 MACROH2A1 HUWE1 LARP7 PDIA6 H2AC1 H2AX H2AZ1 | 1.34e-04 | 593 | 226 | 18 | int:H2AX |
| Interaction | DNAJA2 interactions | IFT172 INSR FANCD2 PARP1 H2AC4 WDR62 TNPO1 BIRC3 UFL1 HUWE1 TBL3 SLC25A12 GTF3C2 GREB1 HPS5 ESPL1 GARRE1 | 1.40e-04 | 542 | 226 | 17 | int:DNAJA2 |
| Interaction | MACROH2A2 interactions | CHD4 PARP1 TONSL MACROH2A2 H2AC11 H3-5 H2AC21 MACROH2A1 LARP7 H2AZ1 | 1.41e-04 | 211 | 226 | 10 | int:MACROH2A2 |
| Interaction | H4C11 interactions | 1.44e-04 | 45 | 226 | 5 | int:H4C11 | |
| Interaction | CA14 interactions | 1.45e-04 | 71 | 226 | 6 | int:CA14 | |
| GeneFamily | Histones | H2AZ2 H2AC14 H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 H2AC12 H2AC11 H3-5 H2AC21 MACROH2A1 H2AC1 H2AC7 H2AX H2AZ1 H2AJ | 3.14e-16 | 116 | 162 | 17 | 864 |
| GeneFamily | Neuroblastoma breakpoint family | 4.20e-08 | 23 | 162 | 6 | 662 | |
| GeneFamily | Myosins, class V | 2.38e-04 | 3 | 162 | 2 | 1100 | |
| GeneFamily | Cadherin related | 4.38e-04 | 17 | 162 | 3 | 24 | |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 1.17e-03 | 6 | 162 | 2 | 1094 | |
| GeneFamily | Phosphodiesterases | 1.24e-03 | 24 | 162 | 3 | 681 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 2.40e-03 | 30 | 162 | 3 | 959 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.91e-03 | 66 | 162 | 4 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.45e-03 | 34 | 162 | 3 | 487 | |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 H2AZ2 STK17B FANCD2 DHX15 H2AC14 H2AC6 H2AC4 H2AC20 DDX46 TONSL H2AC12 WDR62 SEC14L1 H2AC11 KMT5A DCP2 H2AC21 LARP7 RPIA GTF3C2 H2AC7 H2AX H2AZ1 CEP152 ESPL1 | 5.02e-07 | 969 | 231 | 26 | M149 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | ITPKB HEPACAM CFAP299 FAT1 FAT2 DTX4 LRRN2 DNAH7 CBLN4 TENM4 TENM3 HEY1 DMRTA2 CFAP44 | 4.84e-06 | 364 | 231 | 14 | M39057 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | MYO5B STK17B IFT172 SEC24A ATP8B1 BDKRB2 H2AC18 PTPRZ1 DTX4 SLC51A MACROH2A1 XPNPEP1 PDIA6 SLC44A1 HEY1 MTHFR TMEM44 UBR3 TNFAIP2 CFAP44 | 7.61e-06 | 726 | 231 | 20 | M4210 |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | PLCXD1 INSR H2AC6 H2AC20 MRC2 H2AC12 H2AC11 H2AC21 TENM3 H2AC7 | 1.21e-05 | 200 | 231 | 10 | M107 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | SPOCK1 MPDZ ITPKB HEPACAM CFAP299 H2AC6 FAT1 FAT2 DST MRC2 DTX4 LRRN2 MXRA8 DNAH7 SLC44A1 HEY1 CFAP44 | 1.50e-05 | 574 | 231 | 17 | M39056 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KNTC1 H2AZ2 ATR DHX15 FAT1 DDX46 DCP2 MACROH2A1 LCT LARP7 PIKFYVE RPIA H2AX ESPL1 | 2.81e-05 | 426 | 231 | 14 | M9516 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | INSR RPRD1B H2AC6 H2AC4 H2AC18 H2AC12 WDR62 H2AC11 GTF2E1 HEY1 SH3D19 H2AC7 H2AX HPS5 | 2.86e-07 | 236 | 228 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 2.33e-06 | 80 | 228 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 2.52e-06 | 108 | 228 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | MYO5B IL17D H2AC4 H2AC18 H2AC20 H2AC12 WDR62 MPP7 H2AC11 CLDN6 HEY1 H2AC7 H2AX DMRTA2 GREB1 RAB11FIP4 CCDC171 ACSL5 | 6.53e-06 | 491 | 228 | 18 | Facebase_RNAseq_e9.5_Olfactory Placode_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ACO1 INSR RPRD1B H2AC6 H2AC4 H2AC18 H2AC12 WDR62 H2AC11 DET1 GTF2E1 PDIA6 GTF3C2 HEY1 SH3D19 H2AC7 H2AX HPS5 GABPA ACSL5 | 1.61e-05 | 629 | 228 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.77e-05 | 137 | 228 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.50e-05 | 110 | 228 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | KNTC1 IMPDH2 MYO5A TLR7 FANCD2 PARP1 MPP7 MGAM SYNE1 MACROH2A1 LBP PSTPIP2 CTR9 TNFAIP2 CXCR2 | 3.48e-05 | 405 | 228 | 15 | GSM538343_500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | ABCA2 MYO5B RPN2 SVOPL PRSS36 PARP1 H2AC6 H2AC4 H2AC18 H2AC20 DTX4 PCDH19 ZSWIM4 WDR62 H2AC11 RNF44 H2AC21 HUWE1 TENM3 HEY1 H2AC7 H2AX H2AZ1 SMS GREB1 RAB11FIP4 ESPL1 ALG13 | 7.85e-05 | 1187 | 228 | 28 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_100 | 1.05e-04 | 44 | 228 | 5 | gudmap_developingKidney_e12.5_renal vesicle_100_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ABCA2 ACACB MYO5B IL17D H2AC4 H2AC18 H2AC20 PCDH19 SEMA4A FMNL1 H2AC12 WDR62 MPP7 H2AC11 CLDN6 SLC25A12 HEY1 H2AC7 H2AX DMRTA2 GREB1 RAB11FIP4 CCDC171 ACSL5 | 1.35e-04 | 973 | 228 | 24 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_500 | 1.45e-04 | 74 | 228 | 6 | gudmap_developingKidney_e15.5_S-shaped body_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | INSR RPRD1B H2AC6 H2AC4 H2AC18 H2AC20 H2AC12 WDR62 H2AC11 SH3D19 H2AC7 H2AX HPS5 | 1.45e-04 | 359 | 228 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K3 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 2.03e-04 | 148 | 228 | 8 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_200 | 2.35e-04 | 52 | 228 | 5 | gudmap_developingKidney_e12.5_renal vesicle_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | INSR FBXL12 RPRD1B H2AC6 H2AC4 H2AC18 H2AC20 MACROH2A2 FEM1A H2AC12 WDR62 SEC14L1 H2AC11 DCP2 GTF3C2 SH3D19 H2AC7 H2AX HPS5 GABPA ACSL5 | 2.48e-04 | 828 | 228 | 21 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K1 |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | H2AZ2 H2AC6 H2AC4 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 AOC3 H2AC7 H2AX H2AZ1 | 3.40e-10 | 188 | 232 | 12 | be3db9768364568f44e32ae6b3bf99e49b0978bb |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | KNTC1 FANCD2 H2AC14 H2AC4 H2AC20 H2AC12 WDR62 H2AC11 H2AC21 H2AX CEP152 ESPL1 | 5.49e-10 | 196 | 232 | 12 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | STK17B CHN1 FAT1 PTPRZ1 PPFIA2 MXRA8 ACKR4 RGS3 TENM4 HEY1 CPXM1 | 4.95e-09 | 189 | 232 | 11 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | H2AC6 H2AC4 H2AC20 PTPRB H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 H2AX H2AZ1 | 5.52e-09 | 191 | 232 | 11 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | H2AZ2 H2AC6 H2AC4 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 H2AX H2AZ1 | 5.52e-09 | 191 | 232 | 11 | a3c5a913a99f17633c140ec9ece81b73e59e0715 |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | STK17B CHN1 FAT1 PTPRZ1 MRC2 PPFIA2 MXRA8 ACKR4 RGS3 TENM4 CPXM1 | 6.16e-09 | 193 | 232 | 11 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | FANCD2 H2AC6 H2AC4 H2AC20 H2AC12 H2AC11 H2AC21 H2AC7 H2AX H2AZ1 | 4.10e-08 | 181 | 232 | 10 | b6b41cd5d43543fe7a093033dae52a789199db0e |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 OBSCN FAT1 OTOA MGAM PPFIA2 TENM4 PHACTR3 MYO16 DNAH11 | 4.78e-08 | 184 | 232 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 OBSCN FAT1 OTOA MGAM PPFIA2 TENM4 PHACTR3 MYO16 DNAH11 | 4.78e-08 | 184 | 232 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 OBSCN FAT1 OTOA MGAM PPFIA2 TENM4 PHACTR3 MYO16 DNAH11 | 4.78e-08 | 184 | 232 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | H2AC6 H2AC4 H2AC20 H2AC12 H2AC11 H2AC21 H2AC1 H2AC7 H2AX H2AZ1 | 5.86e-08 | 188 | 232 | 10 | b240ea20750ffb825cb5fe41d06c632233406ab6 |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDE2A INSR ATP8B1 PDE10A CHN1 ITPKB PTPRB PIK3C2B SEC14L1 DIPK2B | 7.14e-08 | 192 | 232 | 10 | 27ff3621e177e7932dd44dd6baa81551ea75a874 |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | OBSCN PDE10A CHN1 PTPRB SEC14L1 SYNE1 GRK5 HEY1 TMEM44 SH3D19 | 7.87e-08 | 194 | 232 | 10 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ATP8B1 ITPKB PTPRB DST PIK3C2B DOCK1 GRK5 ARHGEF12 DIPK2B ARHGAP18 | 7.87e-08 | 194 | 232 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | H2AZ2 H2AC6 H2AC4 H2AC20 DCTPP1 H2AC11 KMT5A H2AC7 H2AX H2AZ1 | 7.87e-08 | 194 | 232 | 10 | 5d60262a512590d60bc795d9a0e03c0219e3e15e |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | H2AC6 XPO6 SEC14L1 MGAM H3-5 NBPF10 TNFAIP2 MYO16 CXCR1 CXCR2 | 1.05e-07 | 200 | 232 | 10 | 95c41f147a1594d49e73cb56d86d301c3115ce20 |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 1.24e-07 | 111 | 232 | 8 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.31e-07 | 166 | 232 | 9 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 3.98e-07 | 177 | 232 | 9 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-07 | 179 | 232 | 9 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.38e-07 | 179 | 232 | 9 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 4.59e-07 | 180 | 232 | 9 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-07 | 181 | 232 | 9 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-07 | 181 | 232 | 9 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-07 | 182 | 232 | 9 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 5.27e-07 | 183 | 232 | 9 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.77e-07 | 185 | 232 | 9 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.60e-07 | 188 | 232 | 9 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 7.21e-07 | 190 | 232 | 9 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.21e-07 | 190 | 232 | 9 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.54e-07 | 191 | 232 | 9 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-07 | 193 | 232 | 9 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.22e-07 | 193 | 232 | 9 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-07 | 193 | 232 | 9 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 8.58e-07 | 194 | 232 | 9 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.58e-07 | 194 | 232 | 9 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.96e-07 | 195 | 232 | 9 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-07 | 196 | 232 | 9 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | PDE10A PTPRB SEC14L1 GRK5 DIPK2B HEY1 TMEM44 SH3D19 ARHGAP18 | 9.35e-07 | 196 | 232 | 9 | 0ce3ed27d2b9276390952652c17a8d6de13add36 |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 9.75e-07 | 197 | 232 | 9 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-07 | 197 | 232 | 9 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 9.75e-07 | 197 | 232 | 9 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | MPDZ PTPRB DST SEC14L1 ARHGEF12 TTYH3 DIPK2B ARHGAP18 GARRE1 | 1.11e-06 | 200 | 232 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MPDZ KMT2C PTPRB DST SEC14L1 ARHGEF12 DIPK2B ARHGAP18 GARRE1 | 1.11e-06 | 200 | 232 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-06 | 200 | 232 | 9 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-06 | 200 | 232 | 9 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-06 | 154 | 232 | 8 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.90e-06 | 168 | 232 | 8 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.45e-06 | 172 | 232 | 8 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 176 | 232 | 8 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 176 | 232 | 8 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 125 | 232 | 7 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.27e-06 | 177 | 232 | 8 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.45e-06 | 82 | 232 | 6 | 5cd8e47edb775eabf3e9a407c1c2d8a78afb9509 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.45e-06 | 82 | 232 | 6 | 1eeb259ec555879ee1962b7bc2c31c200fbb85cf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 178 | 232 | 8 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 4.45e-06 | 178 | 232 | 8 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-06 | 179 | 232 | 8 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 181 | 232 | 8 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 181 | 232 | 8 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 5.46e-06 | 183 | 232 | 8 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-06 | 184 | 232 | 8 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-06 | 184 | 232 | 8 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-06 | 187 | 232 | 8 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-06 | 187 | 232 | 8 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.39e-06 | 187 | 232 | 8 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.39e-06 | 187 | 232 | 8 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 6.39e-06 | 187 | 232 | 8 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.65e-06 | 188 | 232 | 8 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 188 | 232 | 8 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.65e-06 | 188 | 232 | 8 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 6.65e-06 | 188 | 232 | 8 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 188 | 232 | 8 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.91e-06 | 189 | 232 | 8 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-06 | 189 | 232 | 8 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 190 | 232 | 8 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 190 | 232 | 8 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-small_pre-B-II_cell|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.18e-06 | 190 | 232 | 8 | f49ceda3622cf079cffde9c9a9e3d0380c571d39 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 190 | 232 | 8 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 191 | 232 | 8 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-06 | 191 | 232 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.47e-06 | 191 | 232 | 8 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 192 | 232 | 8 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.76e-06 | 192 | 232 | 8 | 3ce486cd5171f2d04ac4f7f87bead8b0d8c99c17 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 7.76e-06 | 192 | 232 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 192 | 232 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 192 | 232 | 8 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | COVID-19_Mild-PLT_1|World / Disease Group and Platelet Clusters | 7.76e-06 | 192 | 232 | 8 | c86cb4b2df5102af904c362f3cbd24fe4462ba6c | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.06e-06 | 193 | 232 | 8 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.06e-06 | 193 | 232 | 8 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-06 | 193 | 232 | 8 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 8.37e-06 | 194 | 232 | 8 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.37e-06 | 194 | 232 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.37e-06 | 194 | 232 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.37e-06 | 194 | 232 | 8 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.69e-06 | 195 | 232 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Control-PLT_1|Control / Disease Group and Platelet Clusters | 8.69e-06 | 195 | 232 | 8 | 20ee45983a5675d9fa072d02dd45c6ce8662d7d7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-06 | 195 | 232 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| Computational | Genes in the cancer module 89. | 3.36e-05 | 14 | 151 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 5.97e-05 | 16 | 151 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 7.72e-05 | 17 | 151 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 9.82e-05 | 18 | 151 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 222. | 2.25e-04 | 22 | 151 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 2.25e-04 | 22 | 151 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 2.69e-04 | 23 | 151 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 4.40e-04 | 26 | 151 | 4 | MODULE_127 | |
| Computational | Chromatin. | 5.89e-04 | 28 | 151 | 4 | MODULE_421 | |
| Drug | 5-methyl-dCTP | H2AZ2 MACROH2A2 DCTPP1 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 3.98e-09 | 55 | 230 | 9 | CID000161376 |
| Drug | C04378 | H2AZ2 SPOCK1 MACROH2A2 H2AC21 MACROH2A1 H2AC1 AOC3 H2AX H2AZ1 H2AJ | 1.03e-08 | 82 | 230 | 10 | CID000440315 |
| Drug | N-myristoyl-rkrtlrrl | 1.80e-08 | 46 | 230 | 8 | CID003081274 | |
| Drug | CAS 1400-61-9 | 5.75e-08 | 53 | 230 | 8 | CID000004568 | |
| Drug | AC1L9DEH | H2AZ2 SPOCK1 ACO1 NOD2 FANCD2 PHKA2 PARP1 PIK3C2B TONSL MACROH2A2 H2AC21 CASP9 BIRC3 MACROH2A1 PIKFYVE GTF2E1 H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 CXCR2 | 8.59e-08 | 569 | 230 | 22 | CID000442783 |
| Drug | AC1OCADI | H2AZ2 BDKRB2 H2AC20 PTPRZ1 MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 8.91e-08 | 130 | 230 | 11 | CID006914639 |
| Drug | AC1L9M5N | H2AZ2 IL17D PTPRB TONSL MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 1.13e-07 | 133 | 230 | 11 | CID000448618 |
| Drug | spermine | H2AZ2 PLCXD1 INSR H2AC20 PIK3C2B TONSL MACROH2A2 PLEKHG4 H2AC21 MACROH2A1 LCT PIKFYVE H2AC1 AOC3 H2AX H2AZ1 SMS H2AJ | 1.19e-07 | 394 | 230 | 18 | CID000001103 |
| Drug | DB08184 | H2AZ2 CHD4 MACROH2A2 MGAM H2AC21 MACROH2A1 IDS H2AC1 H2AX H2AZ1 H2AJ ESPL1 | 1.40e-07 | 167 | 230 | 12 | CID009547945 |
| Drug | SK-7041 | 1.56e-07 | 60 | 230 | 8 | CID006918714 | |
| Drug | AlCl3 | H2AZ2 MACROH2A2 MGAM SYNE1 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 2.28e-07 | 113 | 230 | 10 | CID000024012 |
| Drug | butane | H2AZ2 XPO6 MACROH2A2 SYNE1 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 5.04e-07 | 123 | 230 | 10 | CID000007843 |
| Drug | arsenite | H2AZ2 PARP1 PIK3C2B TONSL NR1H2 MACROH2A2 H2AC21 CASP9 MACROH2A1 PIKFYVE H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 GREB1 | 5.41e-07 | 347 | 230 | 16 | CID000000544 |
| Drug | DADS | H2AZ2 BDKRB2 MACROH2A2 H2AC21 CASP9 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 9.04e-07 | 131 | 230 | 10 | CID000016590 |
| Drug | nalidixic acid | ABCA2 H2AZ2 PLCXD1 INSR CHN1 SCN5A SLC9A7 MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 9.58e-07 | 277 | 230 | 14 | CID000004421 |
| Drug | gossypol | H2AZ2 ITPKB H2AC20 TONSL MACROH2A2 H2AC21 CASP9 MACROH2A1 GTF2E1 H2AC1 H2AX H2AZ1 H2AJ | 1.50e-06 | 247 | 230 | 13 | CID000003503 |
| Drug | mustard oil | H2AZ2 BDKRB2 MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 2.42e-06 | 114 | 230 | 9 | CID000005971 |
| Drug | 5-phenylselenylmethyl-2'-deoxyuridine | 3.17e-06 | 11 | 230 | 4 | ctd:C558289 | |
| Drug | 5-methylselenylmethyl-2'-deoxyuridine | 3.17e-06 | 11 | 230 | 4 | ctd:C558288 | |
| Drug | 3-aminobenzamide | H2AZ2 PARP1 MACROH2A2 H2AC21 MACROH2A1 PARP10 H2AC1 H2AX H2AZ1 H2AJ | 4.41e-06 | 156 | 230 | 10 | CID000001645 |
| Drug | 8-bromoguanosine | 4.68e-06 | 93 | 230 | 8 | CID000092977 | |
| Drug | gibberellin (GA | H2AZ2 MACROH2A2 H2AC21 MACROH2A1 SKP1 H2AC1 H2AX H2AZ1 H2AJ GABPA | 7.65e-06 | 166 | 230 | 10 | CID000006466 |
| Drug | NSC618487 | H2AZ2 STK17B PLCXD1 INSR BDKRB2 PARP1 TONSL MACROH2A2 VGF SEC16B H2AC21 CASP9 BIRC3 MACROH2A1 NCSTN PIKFYVE PARP10 GTF2E1 H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 CXCR1 CXCR2 | 9.33e-06 | 933 | 230 | 25 | CID000005279 |
| Drug | glycogen | H2AZ2 INSR PHKA2 LRRN2 MACROH2A2 MGAM H2AC21 LAMP2 MACROH2A1 LCT LIPE H2AC1 AOC3 H2AX H2AZ1 H2AJ | 1.24e-05 | 443 | 230 | 16 | CID000439177 |
| Drug | CGP 41251 | 1.42e-05 | 108 | 230 | 8 | CID000104937 | |
| Drug | gamma-butyrolactone | 1.42e-05 | 108 | 230 | 8 | CID000007302 | |
| Drug | bis(4-hydroxyphenyl)sulfone | PDE2A PDE4C ACACB PLCXD1 INSR SRD5A1 ATG9B CASP9 LBP LIPE TENM3 NBPF9 NBPF10 GREB1 ACSL5 | 1.55e-05 | 401 | 230 | 15 | ctd:C543008 |
| Drug | MgCl2 | H2AZ2 MYO5A MYO5B DHX15 H2AC20 MACROH2A2 MGAM PLEKHG4 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 1.61e-05 | 354 | 230 | 14 | CID000024584 |
| Drug | S-adenosylmethionine | ABR H2AZ2 MACROH2A2 TARBP1 KMT5A H2AC21 MACROH2A1 MTHFR H2AC1 H2AX H2AZ1 SMS H2AJ DOT1L | 1.66e-05 | 355 | 230 | 14 | CID000001079 |
| Drug | myristate | H2AZ2 PIK3R4 MACROH2A2 H2AC21 MACROH2A1 PDXK SLC44A1 GUCA1B H2AC1 H2AX H2AZ1 H2AJ ACSL5 | 1.76e-05 | 310 | 230 | 13 | CID000011005 |
| Drug | Yellow pigment | 1.81e-05 | 81 | 230 | 7 | CID000094326 | |
| Drug | manganese | H2AZ2 ACO1 INSR PIK3R4 PHKA2 H2AC4 FAT2 TONSL MACROH2A2 MGAM H2AC21 CASP9 MACROH2A1 XPNPEP1 PDXK GTF2E1 H2AC1 GUCY2D H2AX H2AZ1 H2AJ CACNA2D3 | 1.88e-05 | 791 | 230 | 22 | CID000023930 |
| Drug | BO-1012 | 1.99e-05 | 6 | 230 | 3 | ctd:C000591165 | |
| Drug | U381 | 1.99e-05 | 6 | 230 | 3 | CID002733286 | |
| Drug | ADP-Rib | ATR FANCD2 PARP1 TONSL CASP9 BIRC3 RGS3 PARP10 RPIA H2AZ1 H2AJ ARHGAP18 | 2.03e-05 | 269 | 230 | 12 | CID000000192 |
| Drug | procainamide | H2AZ2 H2AC20 SCN5A MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 2.48e-05 | 190 | 230 | 10 | CID000004913 |
| Drug | fluoride | H2AZ2 PLCXD1 TONSL MACROH2A2 MGAM H2AC21 MACROH2A1 LCT H2AC1 H2AX H2AZ1 H2AJ | 2.80e-05 | 278 | 230 | 12 | CID000014917 |
| Drug | NaBu | 3.44e-05 | 122 | 230 | 8 | CID000052923 | |
| Drug | oxazolinodaunorubicin | 3.46e-05 | 7 | 230 | 3 | ctd:C552952 | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | TMPRSS15 ABCA2 STK17B LHPP C2CD2L SEMA4A VGF RGS3 SLC44A1 CFAP44 | 3.68e-05 | 199 | 230 | 10 | 5534_DN |
| Drug | Berberine | H2AC14 PARP1 H2AC6 H2AC4 H2AC18 H2AC12 H2AC11 KMT5A CASP9 H2AX | 4.18e-05 | 202 | 230 | 10 | ctd:D001599 |
| Drug | butyrolactone I | 4.85e-05 | 128 | 230 | 8 | CID000123740 | |
| Drug | 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine | 5.49e-05 | 8 | 230 | 3 | ctd:C475622 | |
| Drug | Zlllal | H2AZ2 ACO1 INSR PARP1 TONSL NR1H2 MACROH2A2 H2AC21 CASP9 BIRC3 MACROH2A1 SKP1 PIKFYVE H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 | 5.56e-05 | 613 | 230 | 18 | CID000107707 |
| Drug | chlorambucil | 6.37e-05 | 133 | 230 | 8 | CID000002708 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 6.92e-05 | 173 | 230 | 9 | 5612_UP | |
| Drug | AC1L9HHR | H2AZ2 ATP8B1 CHN1 PARP1 MACROH2A2 H2AC21 CASP9 MACROH2A1 PARP10 H2AC1 H2AX H2AZ1 H2AJ | 6.92e-05 | 354 | 230 | 13 | CID000445141 |
| Drug | carbachol | PDE2A H2AZ2 MYO5A MYO5B PLCXD1 ADORA2B PIK3C2B TONSL MACROH2A2 H2AC21 MACROH2A1 RGS3 PIKFYVE H2AC1 GUCY2D H2AX H2AZ1 H2AJ CACNA2D3 | 7.79e-05 | 688 | 230 | 19 | CID000002551 |
| Drug | maltulose | 8.85e-05 | 45 | 230 | 5 | CID000087177 | |
| Drug | sebacate | 9.79e-05 | 181 | 230 | 9 | CID000005192 | |
| Drug | AC1L8XEZ | 1.02e-04 | 2 | 230 | 2 | CID000434401 | |
| Drug | S-dimethylaminoarsino-thiosuccinic acid | 1.02e-04 | 2 | 230 | 2 | ctd:C552033 | |
| Drug | myricetin | 1.04e-04 | 74 | 230 | 6 | CID005281672 | |
| Drug | AC1L1FWN | H2AZ2 MACROH2A2 H2AC21 CASP9 MACROH2A1 LCT H2AC1 H2AX H2AZ1 H2AJ | 1.11e-04 | 227 | 230 | 10 | CID000003425 |
| Drug | phenanthridone | 1.16e-04 | 10 | 230 | 3 | CID000001853 | |
| Drug | mafosfamide | 1.16e-04 | 10 | 230 | 3 | ctd:C048341 | |
| Drug | SB203580 | H2AZ2 MYO5A MYOD1 INSR IL17D DACT1 PARP1 TONSL MACROH2A2 H2AC21 CASP9 BIRC3 MACROH2A1 PIKFYVE PARP10 H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 | 1.18e-04 | 771 | 230 | 20 | CID000176155 |
| Drug | hydralazine | 1.20e-04 | 186 | 230 | 9 | CID000003637 | |
| Drug | zinc chloride (ZnCl2 | H2AZ2 PIK3R4 MACROH2A2 H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 1.20e-04 | 186 | 230 | 9 | CID000005727 |
| Drug | erythritol anhydride | 1.27e-04 | 26 | 230 | 4 | ctd:C007366 | |
| Drug | 3-aminopropyl | 1.34e-04 | 49 | 230 | 5 | CID000007852 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | KNTC1 ABR ACACB ATR SPOCK1 IL17D RPRD1B FANCD2 DACT1 PARP1 FAT2 NECAB1 SLC9A7 NR1I3 DIP2B SEC16B COG7 H2AC21 BIRC3 FRYL PDXK LARP7 CBLN4 MTHFR BARHL1 GREB1 ESPL1 TATDN1 FGGY ALG13 | 1.36e-04 | 1441 | 230 | 30 | ctd:C009828 |
| Drug | 5-methylcytosine | ABR H2AZ2 MACROH2A2 KMT5A H2AC21 MACROH2A1 H2AC1 H2AX H2AZ1 H2AJ | 1.37e-04 | 233 | 230 | 10 | CID000065040 |
| Drug | propranolol | H2AZ2 BDKRB2 ADORA2B SCN5A MACROH2A2 H2AC21 MACROH2A1 LIPE H2AC1 H2AX H2AZ1 H2AJ TNFAIP2 CACNA2D3 | 1.44e-04 | 434 | 230 | 14 | CID000004946 |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.47e-04 | 191 | 230 | 9 | 6498_UP | |
| Disease | Seckel syndrome 1 | 1.62e-04 | 3 | 218 | 2 | C4551474 | |
| Disease | Crohn's disease (implicated_via_orthology) | 1.62e-04 | 3 | 218 | 2 | DOID:8778 (implicated_via_orthology) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 3.23e-04 | 4 | 218 | 2 | C4551898 | |
| Disease | homocysteine measurement | 3.71e-04 | 46 | 218 | 4 | EFO_0004578 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 5.35e-04 | 5 | 218 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | blood pressure | 5.52e-04 | 22 | 218 | 3 | EFO_0004325 | |
| Disease | bipolar I disorder | 6.50e-04 | 141 | 218 | 6 | EFO_0009963 | |
| Disease | Septicemia | 7.18e-04 | 24 | 218 | 3 | C0036690 | |
| Disease | Sepsis | 7.18e-04 | 24 | 218 | 3 | C0243026 | |
| Disease | Severe Sepsis | 7.18e-04 | 24 | 218 | 3 | C1719672 | |
| Disease | Pyemia | 7.18e-04 | 24 | 218 | 3 | C0034189 | |
| Disease | extracellular superoxide dismutase [Cu-Zn] measurement | 7.99e-04 | 6 | 218 | 2 | EFO_0022018 | |
| Disease | Weight Gain | 9.79e-04 | 102 | 218 | 5 | C0043094 | |
| Disease | Hidradenitis Suppurativa | 1.11e-03 | 7 | 218 | 2 | C0162836 | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 1.11e-03 | 7 | 218 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.11e-03 | 7 | 218 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | hormone measurement, thyroid stimulating hormone measurement | 1.26e-03 | 29 | 218 | 3 | EFO_0004730, EFO_0004748 | |
| Disease | autoimmune disease (is_implicated_in) | 1.48e-03 | 8 | 218 | 2 | DOID:417 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | ABHD15 RPN2 INSR LHPP H2AC6 H2AC4 GCN1 DIP2B SEC16B MGAM FRYL ADAMTS13 GSDMC PARP10 EFR3B H2AC7 RAB11FIP4 DOT1L | 1.53e-03 | 1106 | 218 | 18 | EFO_0021796 |
| Disease | venous thromboembolism, fibrinogen measurement | 1.54e-03 | 67 | 218 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | pulse pressure measurement | INSR PIK3R4 DHX15 FBXO38 H2AC14 H2AC6 MRC2 CORO7 DIP2B KMT5A ARHGEF12 FRYL GSDMC TENM4 MTHFR CPXM1 UBR3 DMRTA2 DOT1L FGGY GARRE1 | 1.61e-03 | 1392 | 218 | 21 | EFO_0005763 |
| Disease | Drug habituation | 1.67e-03 | 115 | 218 | 5 | C0013170 | |
| Disease | Drug abuse | 1.67e-03 | 115 | 218 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.67e-03 | 115 | 218 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.67e-03 | 115 | 218 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.67e-03 | 115 | 218 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.67e-03 | 115 | 218 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.67e-03 | 115 | 218 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.67e-03 | 115 | 218 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.67e-03 | 115 | 218 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.74e-03 | 116 | 218 | 5 | C0740858 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 1.89e-03 | 9 | 218 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 2.35e-03 | 10 | 218 | 2 | EFO_0020778 | |
| Disease | Corneal astigmatism | 2.57e-03 | 77 | 218 | 4 | EFO_1002040 | |
| Disease | liver benign neoplasm (biomarker_via_orthology) | 2.86e-03 | 11 | 218 | 2 | DOID:916 (biomarker_via_orthology) | |
| Disease | gout | 3.46e-03 | 196 | 218 | 6 | EFO_0004274 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.80e-03 | 139 | 218 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 3.91e-03 | 140 | 218 | 5 | C0005695 | |
| Disease | Short Rib-Polydactyly Syndrome | 4.02e-03 | 13 | 218 | 2 | C0036996 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 4.02e-03 | 13 | 218 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of urinary bladder | 4.03e-03 | 141 | 218 | 5 | C0005684 | |
| Disease | very long-chain saturated fatty acid measurement | 4.21e-03 | 44 | 218 | 3 | EFO_0006796 | |
| Disease | Obesity | 4.31e-03 | 205 | 218 | 6 | C0028754 | |
| Disease | Pneumoconiosis | 4.66e-03 | 14 | 218 | 2 | C0032273 | |
| Disease | Bagassosis | 4.66e-03 | 14 | 218 | 2 | C0004681 | |
| Disease | triacylglycerol 46:2 measurement | 4.66e-03 | 14 | 218 | 2 | EFO_0010402 | |
| Disease | Saldino-Noonan Syndrome | 4.66e-03 | 14 | 218 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 4.66e-03 | 14 | 218 | 2 | C0024507 | |
| Disease | obesity (biomarker_via_orthology) | 4.81e-03 | 147 | 218 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | subcutaneous adipose tissue measurement | 5.07e-03 | 93 | 218 | 4 | EFO_0004766 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 5.07e-03 | 93 | 218 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | systemic lupus erythematosus (is_marker_for) | 5.08e-03 | 47 | 218 | 3 | DOID:9074 (is_marker_for) | |
| Disease | age at onset, Myopia | 5.24e-03 | 150 | 218 | 5 | EFO_0004847, HP_0000545 | |
| Disease | Alopecia, Male Pattern | 5.35e-03 | 15 | 218 | 2 | C4083212 | |
| Disease | Autosomal recessive primary microcephaly | 5.35e-03 | 15 | 218 | 2 | cv:C3711387 | |
| Disease | Androgenetic Alopecia | 5.35e-03 | 15 | 218 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 5.35e-03 | 15 | 218 | 2 | C0263477 | |
| Disease | obesity (implicated_via_orthology) | 5.42e-03 | 215 | 218 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | cerebellum white matter volume change measurement | 6.09e-03 | 16 | 218 | 2 | EFO_0021498 | |
| Disease | Dermatitis | 6.09e-03 | 16 | 218 | 2 | C0011603 | |
| Disease | smoking status measurement, systolic blood pressure | 6.17e-03 | 156 | 218 | 5 | EFO_0006335, EFO_0006527 | |
| Disease | Adenoid Cystic Carcinoma | 6.54e-03 | 100 | 218 | 4 | C0010606 | |
| Disease | Inborn Errors of Metabolism | 6.87e-03 | 17 | 218 | 2 | C0025521 | |
| Disease | high altitude adaptation | 6.87e-03 | 17 | 218 | 2 | EFO_0009105 | |
| Disease | graft-versus-host disease (is_implicated_in) | 6.87e-03 | 17 | 218 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | caudal anterior cingulate cortex volume measurement | 6.87e-03 | 17 | 218 | 2 | EFO_0010289 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 6.87e-03 | 17 | 218 | 2 | DOID:8677 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASEEIYINQLEALLL | 101 | Q12979 | |
| SIVDAYVLLNLGDSV | 661 | P21399 | |
| VAEIYLGNLAAADLI | 91 | P30411 | |
| QYEEDILTVLGVLLS | 1041 | O94986 | |
| LDRQLTGLYDALLGA | 246 | P83436 | |
| ESAGQLEIRALSLIY | 296 | Q9NP73 | |
| LILNNGLLSSDYVEI | 166 | O75077 | |
| LTRLLLEGGAYINES | 26 | P0C6C1 | |
| QDALYVALELVIAAL | 6 | P29275 | |
| YITNNALLGREDIDL | 76 | Q8IZF6 | |
| KGEALRQSLEYDLAV | 76 | Q6TFL3 | |
| LEYLTAEILELAGNA | 56 | P0C0S8 | |
| LEYLTAEILELAGNA | 56 | Q8IUE6 | |
| LEYLTAEILELAGNA | 56 | Q16777 | |
| LQSEGLAITYGLLEE | 456 | Q9BYG8 | |
| LEYLTAEILELAGNA | 56 | Q7L7L0 | |
| LEYLTAEILELAGNA | 56 | Q9BTM1 | |
| AAILEYLTAEVLELA | 56 | Q71UI9 | |
| AVIEYLAAEILELAG | 51 | Q9P0M6 | |
| AVLEYLTAEILELAG | 51 | O75367 | |
| LELLAEAGNYSALQR | 241 | Q9BZE3 | |
| VDGALVNELYSLLRD | 156 | Q9Y6B7 | |
| RLNIQSGLEDGDLYD | 146 | Q96SM3 | |
| LTEGYGIQELRVDLA | 2881 | Q96DT5 | |
| TGENYRLVNDLVLDL | 406 | Q13489 | |
| ILLDAYDLSVLGVDQ | 161 | Q3LIE5 | |
| DETLENVLLVQGYLA | 106 | Q8IU60 | |
| LDELGVKALTYNDLI | 551 | Q8TEK3 | |
| VLALQDDYLALISLE | 771 | Q6Q4G3 | |
| QAAEDLLQGYEGEIL | 91 | Q7L5Y6 | |
| ELLNYLAALNDDGDL | 541 | O43143 | |
| DLAYQLLGVLESLRS | 266 | Q9H7Y0 | |
| LLGVLESLRSNDLNY | 271 | Q9H7Y0 | |
| YLDNVLAELAAQGIS | 596 | Q9Y2E6 | |
| ARELQLLYGTAEGLA | 126 | Q96SC8 | |
| LLDDSIAIYIAGNQL | 151 | Q96MT7 | |
| ELGTERTYNVLAILD | 581 | O43520 | |
| ERYVLTNLNIGAELL | 101 | Q76LX8 | |
| ELAREYLQLADDGLV | 121 | Q6UXT9 | |
| DVNLRISGNYLILDG | 1406 | Q9NZN5 | |
| GERLVYEISLQEALA | 356 | Q16853 | |
| TSLYIGLRLNTDLEA | 396 | A6NK89 | |
| AAIEERYGKDLLNLS | 46 | Q9H939 | |
| DDLNGQILSLSLYEA | 561 | Q86YS3 | |
| LSEELLLYEGRNKAA | 571 | P49796 | |
| EYLLSASRVLQAEEL | 276 | P54829 | |
| DNLLDIEVAYSLLRG | 766 | P09874 | |
| ALADVATVLGRALYE | 486 | Q92542 | |
| TDVYILNLAVADLLL | 76 | Q9NPB9 | |
| ADSLLNLVDVELIYG | 806 | O00763 | |
| LLGLLAELRSINEAY | 316 | Q14994 | |
| ALVLIYLSPALDAQE | 656 | Q8TAB3 | |
| EEIIDGSYLNALLDL | 41 | Q7RTW8 | |
| DLELLDATVAQVLLY | 351 | Q7RTW8 | |
| IGSREQLAVLLQLYD | 801 | Q9P260 | |
| DADAGLNRKILYSLI | 3151 | Q14517 | |
| LEEALLQTDYGLHRL | 806 | Q8N6Y1 | |
| YESELGRLAAELQAL | 526 | Q6ZVH7 | |
| DAAIRNYGIELAVSL | 291 | P42898 | |
| GVAERYDILLLTENG | 1021 | P23467 | |
| YAAQEGLLALQSELL | 41 | P18428 | |
| VGLFNAELLEALLNY | 416 | P18428 | |
| ISLDNLSEDGAQLLY | 1381 | Q8NEZ4 | |
| LIASRDIAAGEELLY | 361 | Q9NQR1 | |
| LVRTALEQELGLAAY | 1056 | Q4ZG55 | |
| QRYLLEAAEELGLTD | 256 | Q02846 | |
| LLTYLDENGVDLTSL | 176 | Q9Y6X6 | |
| LATLSELNDGSLLYE | 406 | Q9Y6X6 | |
| GLIDYDTGIRLLETQ | 1576 | Q03001 | |
| DANTGQRLLLYDGDL | 2001 | Q03001 | |
| QRLLLYDGDLDEAVG | 2006 | Q03001 | |
| LIGYSAAELNRLVTE | 406 | Q06546 | |
| QSELGYLANLTELDL | 86 | O75325 | |
| DKYRLDLLAQAGVDV | 256 | P12268 | |
| VAIITDIDLLLGEAY | 936 | O43451 | |
| ILSDIALDDISLTYG | 486 | P98073 | |
| QLDYLDGRLLISSLT | 181 | Q9UPZ3 | |
| LARLNLELYGELEEL | 216 | Q8IWP9 | |
| ERQLLLYEAEALAGG | 706 | P57737 | |
| ALQEASEAYLVGLLE | 91 | Q6NXT2 | |
| LEYLTAEILELAGNA | 56 | P16104 | |
| LDARTGILYVNASLD | 3266 | Q9NYQ8 | |
| DTYILQLLVIADSGL | 191 | Q8NH42 | |
| LDTGGDNQLLLYELS | 86 | Q9Y233 | |
| LQLCGELYDLDASSL | 231 | O00408 | |
| TSLGVLLLDNYSDRI | 521 | Q08493 | |
| YIEGLQALLRDQDAA | 156 | P15172 | |
| LYGLLALISIELANE | 546 | Q9Y2G0 | |
| SVTDVYLLNLALADL | 81 | P25025 | |
| IADLYAEVIGVLAQS | 176 | O94915 | |
| DTGLYELLAALPAQL | 11 | Q5T2T1 | |
| ALYVVGALDETLELR | 1456 | Q9P265 | |
| INEALKAYRLDGIDL | 1296 | P09848 | |
| ELGAQLLSLASYEEE | 706 | Q9UBG0 | |
| AAISEVLYVDLLEGD | 476 | Q4G0J3 | |
| LGAVRSYALELNLTD | 21 | P13473 | |
| YLANDLSLDEASVLI | 2166 | P50748 | |
| EELLEQLYGRLAAGV | 36 | Q8TAD2 | |
| LASYRGDTLLQALDL | 451 | Q92616 | |
| DGYVDNLAEAVDLLL | 251 | Q9H008 | |
| LEANLGLIEEISGYL | 381 | P06213 | |
| DLLLEPSLAQYSDVL | 866 | P23471 | |
| LEYLTAEILELAGNA | 56 | Q6FI13 | |
| SANSILYNGLIEELV | 296 | Q7Z6Z7 | |
| DVTEQLDAGVRYLDL | 91 | Q9NUJ7 | |
| AAELYLNLDLVKEAI | 1351 | Q9UG01 | |
| VEALTAAILDLVELY | 586 | O00750 | |
| SRDLYELLLVATDAG | 501 | Q6V1P9 | |
| DGDLYRLTILDLALG | 61 | Q5VST9 | |
| RLTILDLALGDSGQY | 66 | Q5VST9 | |
| LQIRGLVAEDAGEYL | 3681 | Q5VST9 | |
| ALGSIAIFLEDAVYL | 61 | Q86UW1 | |
| YSQVELGADLALLRL | 131 | Q5K4E3 | |
| ALEVDLGYLIITAAR | 306 | Q6PIJ6 | |
| SHLIIDYSLLVGRDD | 2011 | Q9Y2I7 | |
| YNALLNAGESRLAEL | 1941 | Q13535 | |
| EILAQAYTLLALEGL | 1221 | Q14674 | |
| IEALLLGVYNLEIVD | 101 | Q9BYI3 | |
| AAILDLARGYLTVNI | 16 | Q96ID5 | |
| ERQEATLAGLAELEY | 46 | Q9NYF0 | |
| AKIDYGNRILDLDLV | 151 | Q14185 | |
| QDELALSLGYAASLE | 546 | O14523 | |
| ALLYAALGDVVRSEQ | 21 | Q8IZS8 | |
| DLDDLAILYLATVQA | 416 | Q96C11 | |
| ALESLRGNADLAYIL | 141 | P55211 | |
| LGLVDVLYTAVLDLN | 476 | O15063 | |
| SNELLELILKGLNEY | 1046 | Q8WXX0 | |
| AAVEALELLGATYVD | 296 | Q9BSK4 | |
| VKLLEAARIDGNLDY | 61 | Q6PD62 | |
| RSVTDVYLLNLALAD | 71 | P25024 | |
| VTREAATNGVLLYLD | 156 | Q9NTU7 | |
| LSLDYLLQGTDVVIA | 1781 | Q9BZC7 | |
| SGIEILSLYDAENLG | 226 | Q9ULC5 | |
| ASALLNLYEAPEELL | 226 | O43281 | |
| GALFAALLVLTVYDE | 536 | Q674R7 | |
| ALLVLTVYDEDVLAV | 541 | Q674R7 | |
| NEENRGLDVLLEYLA | 141 | O95466 | |
| AAILEYLTAEVLELA | 56 | P0C0S5 | |
| SLLLSDLQLADEGTY | 106 | Q14CZ8 | |
| LAEVARYLSIIEGLD | 131 | Q9Y5J3 | |
| IAEDNLRALLIYAIS | 281 | Q8WWI5 | |
| YLDTQVGRLLSALDD | 306 | P22304 | |
| KAYAEELASRGLNII | 81 | Q3SXM5 | |
| ALQEELSDVLIYLVA | 91 | Q9H773 | |
| DQARYAGDIIKALEL | 726 | Q7L014 | |
| REAADQLLIVAEGSY | 56 | P15882 | |
| LEYLTAEILELAGNA | 56 | Q96QV6 | |
| NILLDDYGHIRISDL | 316 | P34947 | |
| LEYLTAEILELAGNA | 56 | P04908 | |
| LEYLTAEILELAGNA | 56 | Q93077 | |
| LEYLTAEILELAGNA | 56 | P20671 | |
| LEYLTAEILELAGNA | 56 | Q96KK5 | |
| LEYLTAEILELAGNA | 56 | Q99878 | |
| SGLIRELAAVEDELY | 1426 | Q9NZM4 | |
| LGINLATADTVIIYD | 1131 | Q14839 | |
| EALLRYVLSINEEGL | 361 | Q92503 | |
| LLTAAELLLDYDTGS | 306 | O75995 | |
| IEALLLGIYNLEIAD | 101 | Q8IXS8 | |
| LEEYDTQDGIAINLL | 686 | Q9BXW9 | |
| LIYEASGQDISIAVL | 876 | P46019 | |
| ELEAYLAALTQLRAL | 411 | Q05469 | |
| ILEREYNNLLALGTE | 1166 | O75334 | |
| AGRNSYLEVLLKLAD | 311 | Q15084 | |
| GASVDLLLLELYLEN | 181 | Q53GL7 | |
| LLLYQDEEALNDSII | 376 | Q96KR7 | |
| RQLILQYGLTLSDLD | 136 | P49247 | |
| YGIEHALALDILIRN | 26 | P29083 | |
| GSLNLEDILYLEDTG | 51 | Q9H7C4 | |
| LTEALSLYEEQLGRL | 321 | P52788 | |
| YIIQTGADIALLELE | 121 | Q9BZJ3 | |
| LLAEYNGRLAAELED | 236 | Q9NQG5 | |
| EAAAALIDLDLYIGF | 181 | Q6P1N9 | |
| DLASDLLLQYLLQGG | 326 | O15240 | |
| VDDLNLTSGEIVYLL | 511 | Q5HYK7 | |
| YERALQDLADLLETG | 6591 | Q8NF91 | |
| LYSEGQRLALEALLS | 26 | Q2M2I3 | |
| SLEEQYLGLALDVDR | 906 | P0DPF3 | |
| SLEEQYLGLALDVDR | 981 | Q6P3W6 | |
| SLEEQYLGLALDVDR | 2201 | Q6P3W6 | |
| SLEEQYLGLALDVDR | 3421 | Q6P3W6 | |
| SLEEQYLGLALDVDR | 716 | Q5TI25 | |
| SLEEQYLGLALDVDR | 466 | Q8N660 | |
| SLEEQYLGLALDVDR | 466 | A0A087WUL8 | |
| SLEEQYLGLALDVDR | 1686 | A0A087WUL8 | |
| SLEEQYLGLALDVDR | 2906 | A0A087WUL8 | |
| SLEEQYLGLALDVDR | 366 | P0DPF2 | |
| LEEQYLGLALDVDRT | 611 | P0DPF2 | |
| SLEEQYLGLALDVDR | 1586 | P0DPF2 | |
| LEEQYLGLALDVDRT | 1831 | P0DPF2 | |
| SLEEQYLGLALDVDR | 2806 | P0DPF2 | |
| LEEQYLGLALDVDRT | 3051 | P0DPF2 | |
| SLEEQYLGLALDVDR | 4026 | P0DPF2 | |
| LEEQYLGLALDVDRT | 4271 | P0DPF2 | |
| ELYDRVDGLLHQLTL | 426 | Q58EX7 | |
| LYRVDNLSDEGALNI | 946 | O95486 | |
| REDGYLSGLNNLVDI | 921 | P27987 | |
| AGLQELSYLQRLEVL | 196 | Q9NXK8 | |
| LEYVAALNLVLRGTL | 76 | Q9UMX6 | |
| RLGLDDAEYALLIAI | 361 | P55055 | |
| LYVGAREAILALDIQ | 76 | Q9H3S1 | |
| LLSSGALAFEDIYLE | 1216 | Q14524 | |
| ENTSEIILILEYAAG | 101 | O94768 | |
| ALVVRDGELADLGQY | 111 | A0A087WV53 | |
| SLLLLDGLEEYLAED | 91 | Q6NVH7 | |
| QELYGVLDRLLDQDL | 1466 | Q7Z745 | |
| VLNSDELQELYEGLR | 56 | O00764 | |
| TLLSLGEDGRLAYEQ | 1031 | Q9Y4F9 | |
| YGVILASAELLERDL | 296 | Q8N434 | |
| LSDYSGLQEELQELR | 216 | Q96JN2 | |
| LEDETLARQLVELGY | 36 | Q6V702 | |
| LVAEAQKRELGASLY | 151 | P56747 | |
| DLYNASGRLTLADIE | 276 | O75746 | |
| AYAENIALLAETALR | 481 | Q99570 | |
| EALYELLRDQVLGVL | 126 | Q03169 | |
| LLLDLGLEAEYRIQV | 251 | Q9NQW7 | |
| DELLEINGQILYGRS | 1396 | O75970 | |
| TYLGAEALLQALERN | 996 | Q9HC29 | |
| DLVARLDELGGVYLQ | 186 | P04844 | |
| YAALEAQAIGLLLEL | 266 | Q9UHP6 | |
| ELLAYEGVRAALEAL | 746 | Q12788 | |
| IALSREEAGDAYELL | 396 | Q96HA7 | |
| NYEALLNLAERLGDA | 336 | Q7L0R7 | |
| LEGLLENTDYTVLLQ | 1096 | Q92752 | |
| DLLLDPSEINAIYLD | 261 | Q08629 | |
| ADGELYVADLGNIRI | 1546 | Q6N022 | |
| DLETNYAELVLDVGR | 6 | Q8IYM2 | |
| DQGTLFELILAANYL | 96 | P63208 | |
| NASIITDYNEEGLLL | 1921 | Q9P273 | |
| ASLLQENTEILGYLL | 171 | Q2T9K0 | |
| ENLTELANIEILYLG | 166 | Q9NYK1 | |
| ALIELTALYDVLGIE | 291 | Q8N392 | |
| LLILYDAIGTLADSV | 546 | Q92973 | |
| ELYQRAIVAIGDTLA | 541 | Q96JE7 | |
| ALDLYRVLVSSGQVD | 1426 | O43379 | |
| VLYLIELGLENSAEE | 951 | Q6ZT12 | |
| GVAEERLLAALAYLQ | 6 | P18405 | |
| ALLYLQELAEELSTA | 191 | Q8WUA4 | |
| YLLQRAVEVSAELGA | 286 | Q13395 | |
| DLSSLLQAVGRLAEY | 556 | Q96QU8 | |
| ADVDLYALLFGESVL | 276 | Q96T83 | |
| DRILGYNSLEILAVL | 466 | Q8N5T2 | |
| DTDYQQALLLLGAAA | 36 | Q9C0H2 | |
| VSLLYLGDIEISEDA | 981 | Q9NVE5 | |
| LLGIAQINLADYDSL | 701 | Q9ULE0 | |
| LGQLIDENYLDRLAE | 111 | O94874 | |
| ILEDIGLYLTNLNDS | 1246 | Q9BVV6 | |
| YLNSLEVEELGLARL | 276 | Q86VY4 | |
| ESYLVLALEVALLGL | 461 | Q9H7M6 | |
| ILDIAGLAAVTDNRY | 3681 | Q5THJ4 | |
| VAQLRGALVYELVDS | 566 | Q9Y3Q0 | |
| SLLIRAVEETDAGLY | 121 | Q9BRK3 | |
| DILVGENDLTALSYL | 66 | Q9Y4I1 | |
| DILVGENDLTALSYL | 66 | Q9ULV0 | |
| ADAILELAYTLADGL | 271 | P22033 | |
| YENVLAALEDLNLSI | 96 | Q8N987 |